Vincent DeVita Jr, MD
Amy and Joseph Perella Professor of Medicine (Medical Oncology) and Professor of Epidemiology (Chronic Diseases)
Research & Publications
Biography
News
Coauthors
Selected Publications
- DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology, 11th Edition.DeVita VT, Lawrence TS, Rosenberg SA, (Eds) DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology, 11th Edition. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2018.
- Progress in the Treatment of Hodgkin’s LymphomaLongo DL, DeVita VT. Progress in the Treatment of Hodgkin’s Lymphoma. New England Journal Of Medicine 2017, 378: 392-394. PMID: 29224505, DOI: 10.1056/nejme1715141.
- Vincent T. DeVita on His New Book, "The Death of Cancer," and the Current State of Cancer Care.DeVita V. Vincent T. DeVita on His New Book, "The Death of Cancer," and the Current State of Cancer Care. Oncology 2016, 30: 210. PMID: 26984212.
- A CONVERSATION WITH VINCENT DEVITA, MD. No Truce Sought in Cancer War: 'We Want to Cure This Disease'.DeVita V, Wehrwein P. A CONVERSATION WITH VINCENT DEVITA, MD. No Truce Sought in Cancer War: 'We Want to Cure This Disease'. Managed Care 2016, 25: 39-41. PMID: 26882628.
- Cancer's final act?DeVita V. Cancer's final act? The New Scientist 2015, 228: 26-27. DOI: 10.1016/s0262-4079(15)31556-6.
- The Death of Cancer: After Fifty Years on the Front Lines of Medicine, a Pioneering Oncologist Reveals Why the War on Cancer is Winnable--and How We Can Get ThereDeVita VT, DeVita-Raeburn E. The Death of Cancer: After Fifty Years on the Front Lines of Medicine, a Pioneering Oncologist Reveals Why the War on Cancer is Winnable--and How We Can Get There. New York, NY, Sarah Crighton Books at Farrar, Straus and Giroux, November 3, 2015.
- Clinical cancer research: the past, present and the futureDeVita VT, Eggermont AM, Hellman S, Kerr DJ. Clinical cancer research: the past, present and the future. Nature Reviews Clinical Oncology 2014, 11: 663-669. PMID: 25245981, DOI: 10.1038/nrclinonc.2014.153.
- Treatment of Hodgkin Lymphoma: A 50-Year PerspectiveCanellos GP, Rosenberg SA, Friedberg JW, Lister TA, DeVita VT. Treatment of Hodgkin Lymphoma: A 50-Year Perspective. Journal Of Clinical Oncology 2014, 32: 163-168. PMID: 24441526, DOI: 10.1200/jco.2013.53.1194.
- Emil Frei III: A Personal RemembranceCanellos G, DeVita V. Emil Frei III: A Personal Remembrance. The Oncologist 2013, 18: 892-893. PMCID: PMC3720644, DOI: 10.1634/theoncologist.2013-0214.
- Correction: Hematology in 2010: New therapies and standard of care in oncologyDeVita V, Canellos G. Correction: Hematology in 2010: New therapies and standard of care in oncology. Nature Reviews Clinical Oncology 2011, 8: 384-384. DOI: 10.1038/nrclinonc.2011.93.
- Focus issue on biomarkersHutchinson L, DeVita V. Focus issue on biomarkers. Nature Reviews Clinical Oncology 2010, 7: 295-295. PMID: 20517335, DOI: 10.1038/nrclinonc.2010.70.
- A breakthrough in Hodgkin's diseaseDeVita V. A breakthrough in Hodgkin's disease. Nature Reviews Clinical Oncology 2010, 7: 179-179. PMID: 20354537, DOI: 10.1038/nrclinonc.2010.36.
- Breast cancer screening and mortalityDeVita V. Breast cancer screening and mortality. Nature Reviews Clinical Oncology 2010, 7: 65-65. PMID: 20118972, DOI: 10.1038/nrclinonc.2009.232.
- Conflict of interest disclosuresHutchinson L, DeVita V. Conflict of interest disclosures. Nature Reviews Clinical Oncology 2010, 7: 1-1. PMID: 20029440, DOI: 10.1038/nrclinonc.2009.215.
- The NIH entitlement programDeVita V. The NIH entitlement program. Nature Reviews Clinical Oncology 2009, 6: 613-613. PMID: 19861989, DOI: 10.1038/nrclinonc.2009.164.
- We have met the enemy and he is us!DeVita V. We have met the enemy and he is us! Nature Reviews Clinical Oncology 2009, 6: 493-493. PMID: 19707237, DOI: 10.1038/nrclinonc.2009.89.
- The most important news at ASCO 2009DeVita V. The most important news at ASCO 2009. Nature Reviews Clinical Oncology 2009, 6: 371-371. PMID: 19561629, DOI: 10.1038/nrclinonc.2009.93.
- The struggles of cancer centersDeVita V. The struggles of cancer centers. Nature Reviews Clinical Oncology 2009, 6: 241-241. PMID: 19390544, DOI: 10.1038/nrclinonc.2009.51.
- Off-label use of approved drugsDeVita V. Off-label use of approved drugs. Nature Reviews Clinical Oncology 2009, 6: 181-181. PMID: 19333219, DOI: 10.1038/nrclinonc.2009.41.
- News the public should rely onDeVita V. News the public should rely on. Nature Reviews Clinical Oncology 2009, 6: 59-59. PMID: 19180108, DOI: 10.1038/ncponc1301.
- The clinical trials system is brokenDeVita V. The clinical trials system is broken. Nature Reviews Clinical Oncology 2008, 5: 683-683. PMID: 19034294, DOI: 10.1038/ncponc1263.
- The era of personalized medicine: back to basicsHutchinson L, DeVita V. The era of personalized medicine: back to basics. Nature Reviews Clinical Oncology 2008, 5: 623-623. PMID: 18957968, DOI: 10.1038/ncponc1253.
- More on strong inferenceDeVita V. More on strong inference. Nature Reviews Clinical Oncology 2008, 5: 239-239. PMID: 18437157, DOI: 10.1038/ncponc1126.
- Strong inferenceDeVita V. Strong inference. Nature Reviews Clinical Oncology 2008, 5: 177-177. PMID: 18376422, DOI: 10.1038/ncponc1094.
- Health insurance reform—beware of the general solution for the specific problemDeVita V. Health insurance reform—beware of the general solution for the specific problem. Nature Reviews Clinical Oncology 2008, 5: 59-59. PMID: 18235439, DOI: 10.1038/ncponc1046.
- The Provenge® decisionDeVita V. The Provenge® decision. Nature Reviews Clinical Oncology 2007, 4: 381-381. PMID: 17554239, DOI: 10.1038/ncponc0854.
- Letter From the EditorsDeVita V, Lawrence T, Rosenberg S. Letter From the Editors. The Cancer Journal 2007, 13: 1. DOI: 10.1097/ppo.0b013e318053e2f6.
- A step in the right directionDeVita V. A step in the right direction. Nature Reviews Clinical Oncology 2006, 3: 641-641. PMID: 17139311, DOI: 10.1038/ncponc0669.
- A Prospective Trial of Radiation Alone vs Combination Chemotherapy Alone for Early-Stage Hodgkin's Disease: Implications of 25-Year Follow-Up to Current Combined Modality Therapy.Longo D, Glatstein E, Duffey P, Young R, Fiem S, Jaffe E, Camphausen K, Wilson W, DeVita V. A Prospective Trial of Radiation Alone vs Combination Chemotherapy Alone for Early-Stage Hodgkin's Disease: Implications of 25-Year Follow-Up to Current Combined Modality Therapy. Blood 2006, 108: 98. DOI: 10.1182/blood.v108.11.98.98.
- Let's return to the “belly bath”DeVita V. Let's return to the “belly bath”. Nature Reviews Clinical Oncology 2006, 3: 405-405. PMID: 16894365, DOI: 10.1038/ncponc0568.
- The concept of cureDeVita V. The concept of cure. Nature Reviews Clinical Oncology 2006, 3: 59-59. PMID: 16462824, DOI: 10.1038/ncponc0422.
- A Book Review of: “UICC Manual of Clinical Oncology”DeVita V. A Book Review of: “UICC Manual of Clinical Oncology”. Cancer Investigation 2006, 24: 106-106. DOI: 10.1080/07357900500449736.
- Herceptin: HERalding a new era in breast cancer care but at what cost?Hutchinson L, DeVita V. Herceptin: HERalding a new era in breast cancer care but at what cost? Nature Reviews Clinical Oncology 2005, 2: 595-595. PMID: 16341094, DOI: 10.1038/ncponc0378.
- Shifting paradigms in lung cancerDeVita V. Shifting paradigms in lung cancer. Nature Reviews Clinical Oncology 2005, 2: 535-535. PMID: 16270076, DOI: 10.1038/ncponc0345.
- Nature Clinical Practice Oncology: pound for pound a better choice!DeVita V. Nature Clinical Practice Oncology: pound for pound a better choice! Nature Reviews Clinical Oncology 2005, 2: 479-479. DOI: 10.1038/ncponc0321.
- Should the FDA be the doctor of last resort?DeVita V. Should the FDA be the doctor of last resort? Nature Reviews Clinical Oncology 2005, 2: 423-423. PMID: 16264991, DOI: 10.1038/ncponc0292.
- The Framework Convention on Tobacco ControlDeVita V. The Framework Convention on Tobacco Control. Nature Reviews Clinical Oncology 2005, 2: 171-171. PMID: 16264911, DOI: 10.1038/ncponc0133.
- Treatment UtopiaDeVita V. Treatment Utopia. Nature Reviews Clinical Oncology 2005, 2: 59-59. PMID: 16264858, DOI: 10.1038/ncponc0083.
- The curse of the cureDeVita V. The curse of the cure. Nature Reviews Clinical Oncology 2005, 2: 1-1. PMID: 16264829, DOI: 10.1038/ncponc0054.
- The 'War on Cancer' and its impactDeVita V. The 'War on Cancer' and its impact. Nature Reviews Clinical Oncology 2004, 1: 55-55. PMID: 16264801, DOI: 10.1038/ncponc0036.
- Do we need yet another journal?DeVita V. Do we need yet another journal? Nature Reviews Clinical Oncology 2004, 1: 1-1. DOI: 10.1038/ncponc0027.
- FROM THE EDITORSDeVita V, Hellman S, Rosenberg S. FROM THE EDITORS. The Cancer Journal 2003, 9: 231. DOI: 10.1097/00130404-200307000-00001.
- FROM THE EDITORSDeVita V, Hellman S, Rosenberg S. FROM THE EDITORS. The Cancer Journal 2003, 9: 147. DOI: 10.1097/00130404-200305000-00001.
- FROM THE EDITORSDeVita V, Hellman S, Rosenberg S. FROM THE EDITORS. The Cancer Journal 2003, 9: 1. DOI: 10.1097/00130404-200301000-00001.
- FROM THE EDITORSDeVita V, Hellman S, Rosenberg S. FROM THE EDITORS. The Cancer Journal 2002, 8: 415. DOI: 10.1097/00130404-200211000-00001.
- FROM THE EDITORSDeVita V, Hellman S, Rosenberg S. FROM THE EDITORS. The Cancer Journal 2002, 8: 351. DOI: 10.1097/00130404-200209000-00001.
- FROM THE EDITORSDeVita V, Hellman S, Rosenberg S. FROM THE EDITORS. The Cancer Journal 2002, 8: 287. DOI: 10.1097/00130404-200207000-00001.
- FROM THE EDITORSDeVita V, Hellman S, Rosenberg S. FROM THE EDITORS. The Cancer Journal 2002, 8: 207. DOI: 10.1097/00130404-200205000-00001.
- Paul Carbone: 1931-2002DeVita V. Paul Carbone: 1931-2002. The Oncologist 2002, 7: 92-93. DOI: 10.1634/theoncologist.7-2-92.
- FROM THE EDITORSDeVita V, Hellman S, Rosenberg S. FROM THE EDITORS. The Cancer Journal 2002, 8: 81. DOI: 10.1097/00130404-200203000-00001.
- Book ReviewDeVita V. Book Review. New England Journal Of Medicine 2001, 344: 1335-1336. DOI: 10.1056/nejm200104263441717.
- Therapeutic implications of the new biology.DeVita V, Abou-Alfa G. Therapeutic implications of the new biology. The Cancer Journal 2000, 6 Suppl 2: s113-20. PMID: 10803824.
- The lymphomas.DeVita V, Canellos G. The lymphomas. Seminars In Hematology 1999, 36: 84-94. PMID: 10595757.
- Hodgkin's disease and transplantation: a room with a (nontransplanter's) view.Marshall N, DeVita V. Hodgkin's disease and transplantation: a room with a (nontransplanter's) view. Seminars In Oncology 1999, 26: 67-73. PMID: 10073563.
- Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.Longo D, Glatstein E, Duffey P, Young R, Ihde D, Bastian A, Wilson W, Wittes R, Jaffe E, Hubbard S, DeVita V. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease. Journal Of Clinical Oncology 1997, 15: 3338-46. PMID: 9363863, DOI: 10.1200/jco.1997.15.11.3338.
- Late sequelae of treatment of Hodgkin's diseaseDeVita V. Late sequelae of treatment of Hodgkin's disease. Current Opinion In Oncology 1997, 9: 428-431. PMID: 9327220, DOI: 10.1097/00001622-199709050-00006.
- The war on cancer has a birthday, and a present.DeVita V. The war on cancer has a birthday, and a present. Journal Of Clinical Oncology 1997, 15: 867-9. PMID: 9060521, DOI: 10.1200/jco.1997.15.3.867.
- OncologyDeVita V. Oncology. JAMA 1996, 275: 1833-1834. DOI: 10.1001/jama.275.23.1833.
- OncologyDeVita V, Deisseroth A. Oncology. JAMA 1996, 275: 1833-1834. PMID: 8642736, DOI: 10.1001/jama.1996.03530470061036.
- Diffuse Small Noncleaved-Cell, Non-Burkitt's Lymphoma in AdultsLongo D, Duffey P, Jaffe E, Raffeld M, Hubbard S, Fisher R, Wittes R, DeVita V, Young R. Diffuse Small Noncleaved-Cell, Non-Burkitt's Lymphoma in Adults. Journal Of Clinical Oncology 1996, 14: 1969-1969. DOI: 10.1200/jco.1996.14.6.1969.
- Leader in war on cancer looks ahead: talking with Vincent T. DeVita, Jr, MD.Devita V. Leader in war on cancer looks ahead: talking with Vincent T. DeVita, Jr, MD. JAMA 1995, 273: 525-7. PMID: 7837381, DOI: 10.1001/jama.273.7.525.
- The cell cycle: Probing new molecular determinants of resistance and sensitivity to cytotoxic agents.Deisseroth A, DeVita V. The cell cycle: Probing new molecular determinants of resistance and sensitivity to cytotoxic agents. The Cancer Journal 1995, 1: 15-21. PMID: 9166447.
- Diffuse small noncleaved-cell, non-Burkitt's lymphoma in adults: a high-grade lymphoma responsive to ProMACE-based combination chemotherapy.Longo D, Duffey P, Jaffe E, Raffeld M, Hubbard S, Fisher R, Wittes R, DeVita V, Young R. Diffuse small noncleaved-cell, non-Burkitt's lymphoma in adults: a high-grade lymphoma responsive to ProMACE-based combination chemotherapy. Journal Of Clinical Oncology 1994, 12: 2153-9. PMID: 7523607, DOI: 10.1200/jco.1994.12.10.2153.
- Lymphomas.Kwak L, DeVita V, Longo D. Lymphomas. 1994, 15: 413-70. PMID: 7779591.
- Dose IntensitySURBONE A, DeVITA V. Dose Intensity. Annals Of The New York Academy Of Sciences 1993, 698: 279-288. PMID: 8279768, DOI: 10.1111/j.1749-6632.1993.tb17219.x.
- CHOP versus Intensive Regimens in Non-Hodgkin's LymphomaLongo D, DeVita V, Young R. CHOP versus Intensive Regimens in Non-Hodgkin's Lymphoma. New England Journal Of Medicine 1993, 329: 580-582. PMID: 7687747, DOI: 10.1056/nejm199308193290817.
- Hodgkin's DiseaseWood A, DeVita V, Hubbard S. Hodgkin's Disease. New England Journal Of Medicine 1993, 328: 560-565. PMID: 8426624, DOI: 10.1056/nejm199302253280808.
- Lymphomas.Kwak L, DeVita V, Longo D. Lymphomas. 1993, 14: 383-426. PMID: 8312110.
- Is alternating cyclic chemotherapy better than standard four-drug chemotherapy for Hodgkin's disease? No.DeVita V. Is alternating cyclic chemotherapy better than standard four-drug chemotherapy for Hodgkin's disease? No. Important Advances In Oncology 1993, 197-208. PMID: 8505053.
- Radiation therapy is better than chemotherapy in early-stage Hodgkin's disease? Not so fast.Longo D, Duffey P, Hubbard S, Young R, DeVita V. Radiation therapy is better than chemotherapy in early-stage Hodgkin's disease? Not so fast. Journal Of Clinical Oncology 1992, 10: 1367-9. PMID: 1634930, DOI: 10.1200/jco.1992.10.8.1367.
- Biologic Therapy of CancerReid R, DeVita V, Hellman S, Rosenberg S. Biologic Therapy of Cancer. Histopathology 1992, 20: 278-278. DOI: 10.1111/j.1365-2559.1992.tb00973.x.
- Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure.Longo D, Duffey P, Young R, Hubbard S, Ihde D, Glatstein E, Phares J, Jaffe E, Urba W, DeVita V. Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure. Journal Of Clinical Oncology 1992, 10: 210-8. PMID: 1732422, DOI: 10.1200/jco.1992.10.2.210.
- Lymphomas.Longo D, DeVita V. Lymphomas. 1992, 13: 349-403. PMID: 1389915.
- The use of combination chemotherapy in the treatment of early stage Hodgkin's disease.Longo D, DeVita V. The use of combination chemotherapy in the treatment of early stage Hodgkin's disease. Important Advances In Oncology 1992, 155-65. PMID: 1582671.
- The calculation of actual or received dose intensity: a comparison of published methods.Longo D, Duffey P, DeVita V, Wesley M, Hubbard S, Young R. The calculation of actual or received dose intensity: a comparison of published methods. Journal Of Clinical Oncology 1991, 9: 2042-51. PMID: 1941063, DOI: 10.1200/jco.1991.9.11.2042.
- On clinical alerts.DeVita V. On clinical alerts. Annals Of Internal Medicine 1991, 115: 234-5. PMID: 2058884, DOI: 10.7326/0003-4819-115-3-234_2.
- Treatment of advanced-stage Hodgkin's disease: alternating noncrossresistant MOPP/CABS is not superior to MOPP.Longo D, Duffey P, DeVita V, Wiernik P, Hubbard S, Phares J, Bastian A, Jaffe E, Young R. Treatment of advanced-stage Hodgkin's disease: alternating noncrossresistant MOPP/CABS is not superior to MOPP. Journal Of Clinical Oncology 1991, 9: 1409-20. PMID: 1712836, DOI: 10.1200/jco.1991.9.8.1409.
- Important Advances in OncologyDeVita V, Hellman S, Rosenberg S. Important Advances in Oncology. Anti-Cancer Drugs 1991, 2: 419. DOI: 10.1097/00001813-199108000-00014.
- Superiority of ProMACE-CytaBOM Over ProMACE-MOPP in the Treatment of Advanced Diffuse Aggressive LymphomaLongo D, DeVita V, Duffey P, Wesley M, Ihde D, Hubbard S, Gilliom M, Jaffe E, Cossman J, Fisher R, Young R. Superiority of ProMACE-CytaBOM Over ProMACE-MOPP in the Treatment of Advanced Diffuse Aggressive Lymphoma. Journal Of Clinical Oncology 1991, 9: 710-710. DOI: 10.1200/jco.1991.9.4.710.
- Treatment of advanced-stage massive mediastinal Hodgkin's disease: the case for combined modality treatment.Longo D, Russo A, Duffey P, Hubbard S, Glatstein E, Hill J, Jaffe E, Young R, DeVita V. Treatment of advanced-stage massive mediastinal Hodgkin's disease: the case for combined modality treatment. Journal Of Clinical Oncology 1991, 9: 227-35. PMID: 1988570, DOI: 10.1200/jco.1991.9.2.227.
- The influence of information on drug resistance on protocol design The Henry Kaplan Memorial Lecture, International Conference on Mulignant Lymphomas, 6–9 June 1990, Lugano, SwitzerlandDeVita V. The influence of information on drug resistance on protocol design The Henry Kaplan Memorial Lecture, International Conference on Mulignant Lymphomas, 6–9 June 1990, Lugano, Switzerland. Annals Of Oncology 1991, 2: 93-106. PMID: 2054322, DOI: 10.1093/oxfordjournals.annonc.a057892.
- Is a mechanism such as the NCI's Clinical Alert ever an appropriate alternative to journal peer review?DeVita V. Is a mechanism such as the NCI's Clinical Alert ever an appropriate alternative to journal peer review? Important Advances In Oncology 1991, 241-54. PMID: 1869279.
- Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial.Longo D, DeVita V, Duffey P, Wesley M, Ihde D, Hubbard S, Gilliom M, Jaffe E, Cossman J, Fisher R. Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial. Journal Of Clinical Oncology 1991, 9: 25-38. PMID: 1702144, DOI: 10.1200/jco.1991.9.1.25.
- Lymphomas.Longo D, Devita V. Lymphomas. 1991, 12: 347-93. PMID: 1931450.
- Long-term follow-up of ProMACE-CytaBOM in non-Hodgkin's lymphomasFisher R, Longo D, DeVita V, Hubbard S, Miller T, Young R. Long-term follow-up of ProMACE-CytaBOM in non-Hodgkin's lymphomas. Annals Of Oncology 1991, 2: 33-35. PMID: 1710487, DOI: 10.1093/annonc/2.suppl_1.33.
- Primary Chemotherapy Can Avoid Mastectomy, but There Is More to It Than ThatDeVita V. Primary Chemotherapy Can Avoid Mastectomy, but There Is More to It Than That. Journal Of The National Cancer Institute 1990, 82: 1528-1528. PMID: 2205725, DOI: 10.1093/jnci/82.19.1528.
- Lymphomas.Longo D, DeVita V. Lymphomas. 1990, 11: 343-78. PMID: 2223399.
- System of Scientific Advisory Boards at the National Cancer InstituteRambaut P, Bynum B, DeVita V. System of Scientific Advisory Boards at the National Cancer Institute. Journal Of The National Cancer Institute 1989, 81: 1365-1369. PMID: 2778822, DOI: 10.1093/jnci/81.18.1365.
- Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapy.Longo D, Glatstein E, Duffey P, Ihde D, Hubbard S, Fisher R, Jaffe E, Gilliom M, Young R, DeVita V. Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapy. Journal Of Clinical Oncology 1989, 7: 1295-302. PMID: 2788716, DOI: 10.1200/jco.1989.7.9.1295.
- NCI's breast cancer clinical alert: rationale and results.DeVita V, Hubbard S. NCI's breast cancer clinical alert: rationale and results. Resident & Staff Physician 1989, 35: 49-55. PMID: 10303742.
- Breast Cancer Therapy: Exercising All Our OptionsDeVita V. Breast Cancer Therapy: Exercising All Our Options. New England Journal Of Medicine 1989, 320: 527-529. PMID: 2915656, DOI: 10.1056/nejm198902233200812.
- Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: significance and management.Surbone A, Longo D, DeVita V, Ihde D, Duffey P, Jaffe E, Solomon D, Hubbard S, Young R. Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: significance and management. Journal Of Clinical Oncology 1988, 6: 1832-7. PMID: 3199167, DOI: 10.1200/jco.1988.6.12.1832.
- Keeping up with the cancer literature--PDQ ACCESS.Perry D, Sloane E, Hubbard S, Tingley D, DeVita V. Keeping up with the cancer literature--PDQ ACCESS. Journal Of Clinical Oncology 1988, 6: 1649-52. PMID: 3171630, DOI: 10.1200/jco.1988.6.10.1649.
- The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatment.Young R, Longo D, Glatstein E, Ihde D, Jaffe E, DeVita V. The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatment. Seminars In Hematology 1988, 25: 11-6. PMID: 2456618.
- The role of chemotherapy in diffuse aggressive lymphomas.DeVita V, Hubbard S, Young R, Longo D. The role of chemotherapy in diffuse aggressive lymphomas. Seminars In Hematology 1988, 25: 2-10. PMID: 3041598.
- Cytogenetic Studies in Patients With Secondary Leukemia/Dysmyelopoietic Syndrome After Different Treatment ModalitiesWhang-Peng J, Young R, Lee E, Longo D, Schechter G, DeVita V. Cytogenetic Studies in Patients With Secondary Leukemia/Dysmyelopoietic Syndrome After Different Treatment Modalities. Blood 1988, 71: 403-414. DOI: 10.1182/blood.v71.2.403.403.
- Cytogenetic studies in patients with secondary leukemia/dysmyelopoietic syndrome after different treatment modalities.Whang-Peng J, Young R, Lee E, Longo D, Schechter G, DeVita V. Cytogenetic studies in patients with secondary leukemia/dysmyelopoietic syndrome after different treatment modalities. Blood 1988, 71: 403-14. PMID: 3337904, DOI: 10.1182/blood.v71.2.403.bloodjournal712403.
- On the value of response criteria in therapeutic research.Devita V. On the value of response criteria in therapeutic research. Bulletin Du Cancer 1988, 75: 863-9. PMID: 3061500.
- Lymphomas.Longo D, Devita V. Lymphomas. 1988, 10: 148-81. PMID: 3079382.
- The Year 2000 Award for Mary LaskerDeVita V. The Year 2000 Award for Mary Lasker. Journal Of The National Cancer Institute 1987, 79: np1-np1. DOI: 10.1093/jnci/79.4.np1.
- The evolution of chemotherapy of lymphomas of adults.DeVita V. The evolution of chemotherapy of lymphomas of adults. Leukemia 1987, 1: 467-85. PMID: 3312842.
- A computer data base for information on cancer treatmentHubbard S, Henney J, DeVita V. A computer data base for information on cancer treatment. CA A Cancer Journal For Clinicians 1987, 37: 186-192. DOI: 10.3322/canjclin.37.3.186.
- Developmental therapeutics and the acquired immunodeficiency syndrome.DeVita V, Broder S, Fauci A, Kovacs J, Chabner B. Developmental therapeutics and the acquired immunodeficiency syndrome. Annals Of Internal Medicine 1987, 106: 568-81. PMID: 2435201, DOI: 10.7326/0003-4819-106-4-568.
- Decreasing Risk of Leukemia with Prolonged Follow-up after Chemotherapy and Radiotherapy for Hodgkin's DiseaseBlayney D, Longo D, Young R, Greene M, Hubbard S, Postal M, Duffey P, DeVita V. Decreasing Risk of Leukemia with Prolonged Follow-up after Chemotherapy and Radiotherapy for Hodgkin's Disease. New England Journal Of Medicine 1987, 316: 710-714. PMID: 3821809, DOI: 10.1056/nejm198703193161203.
- The Emergence of Biologicals as Cancer Treatment: The Good News and The BadDevita V, Roper M. The Emergence of Biologicals as Cancer Treatment: The Good News and The Bad. Hospital Practice 1987, 22: 15-21. PMID: 3100560, DOI: 10.1080/21548331.1987.11707666.
- A Computer Data Base for Information on Cancer TreatmentHubbard S, Henney J, DeVita V. A Computer Data Base for Information on Cancer Treatment. New England Journal Of Medicine 1987, 316: 315-318. PMID: 3543675, DOI: 10.1056/nejm198702053160606.
- MOPP after two decades.Longo D, Young R, Duffey P, Hubbard S, DeVita V. MOPP after two decades. Journal Of Clinical Oncology 1987, 5: 320-1. PMID: 3806177, DOI: 10.1200/jco.1987.5.2.320.
- PDQ: an innovation in information dissemination linking cancer research and clinical practice.Hubbard S, DeVita V. PDQ: an innovation in information dissemination linking cancer research and clinical practice. Important Advances In Oncology 1987, 263-77. PMID: 3331383.
- Lymphomas.Longo D, Devita V. Lymphomas. 1987, 9: 165-99. PMID: 3079402.
- The lymphomas: biologic implications of therapy and therapeutic implications of the new biology.DeVita V, Longo D, Hubbard S, Young R, Chabner B. The lymphomas: biologic implications of therapy and therapeutic implications of the new biology. International Academy Of Pathology Monograph 1987, 249-67. PMID: 3295522.
- Hematologic malignancies: non-Hodgkin's lymphomas.DeVita V. Hematologic malignancies: non-Hodgkin's lymphomas. Hospital Practice 1986, 21: 103-18. PMID: 2427535.
- Twenty years of MOPP therapy for Hodgkin's disease.Longo D, Young R, Wesley M, Hubbard S, Duffey P, Jaffe E, DeVita V. Twenty years of MOPP therapy for Hodgkin's disease. Journal Of Clinical Oncology 1986, 4: 1295-306. PMID: 3528400, DOI: 10.1200/jco.1986.4.9.1295.
- The Next Fifteen YearsDeVita V. The Next Fifteen Years. Oncology Issues 1986, 1: 15-15. DOI: 10.1080/08986053.1986.11904865.
- Dose-response is alive and well.DeVita V. Dose-response is alive and well. Journal Of Clinical Oncology 1986, 4: 1157-9. PMID: 3525764, DOI: 10.1200/jco.1986.4.8.1157.
- The effect of combined modality therapy on local control and survivalDeVita V, Lippman M, Hubbard S, Ihde D, Rosenberg S. The effect of combined modality therapy on local control and survival. International Journal Of Radiation Oncology • Biology • Physics 1986, 12: 487-501. PMID: 3009367, DOI: 10.1016/0360-3016(86)90056-8.
- Lung cancer rates are alarming and are NCI's greatest challenge.DeVita V. Lung cancer rates are alarming and are NCI's greatest challenge. Public Health Reports 1986, 101: 5. PMID: 3080790, PMCID: PMC1477644.
- The Physician Data Query (PDQ) cancer information system.Hubbard S, Martin N, Blankenbaker L, Esterhay R, Masys D, Tingley D, Stram M, DeVita V. The Physician Data Query (PDQ) cancer information system. Journal Of Cancer Education 1986, 1: 79-87. PMID: 3079208, DOI: 10.1080/08858198609527818.
- Current Management of Hodgkin’s DiseaseBehrens B, Young R, DeVita V. Current Management of Hodgkin’s Disease. Drugs 1985, 30: 355-367. PMID: 3905335, DOI: 10.2165/00003495-198530040-00004.
- Abnormal coagulation results in patients with hodgkin's diseaseSeifter E, Parker R, Gralnick H, Wesley M, DeVita V, Young R, Longo D. Abnormal coagulation results in patients with hodgkin's disease. The American Journal Of Medicine 1985, 78: 942-950. PMID: 3160235, DOI: 10.1016/0002-9343(85)90216-5.
- Renal involvement in diffuse aggressive lymphomas: results of treatment with combination chemotherapy.Geffen D, Fisher R, Longo D, Young R, DeVita V. Renal involvement in diffuse aggressive lymphomas: results of treatment with combination chemotherapy. Journal Of Clinical Oncology 1985, 3: 646-53. PMID: 3998781, DOI: 10.1200/jco.1985.3.5.646.
- ProMACE-MOPP combination chemotherapy for diffuse lymphomas.Fisher R, Young R, Longo D, DeVita V. ProMACE-MOPP combination chemotherapy for diffuse lymphomas. Seminars In Oncology 1985, 12: 29-32. PMID: 2579441.
- Cancer as a preventable disease.DeVita V. Cancer as a preventable disease. Maryland Medical Journal 1985, 34: 41-3. PMID: 3849643.
- We can prevent cancer.DeVita V. We can prevent cancer. The Journal Of The Florida Medical Association 1985, 72: 20-1. PMID: 4056707.
- What are clinical trials all about?DeVita V. What are clinical trials all about? Journal Of Pediatric Hematology/Oncology Nursing 1985, 2: 36. PMID: 3908649.
- Cancer Prevention Awareness Program: targeting black Americans.DeVita V. Cancer Prevention Awareness Program: targeting black Americans. Public Health Reports 1985, 100: 253-4. PMID: 3923529, PMCID: PMC1424758.
- The current status of NCI trials in Hodgkin’s diseaseYoung R, Longo D, Glatstein E, Duffey P, Winkler C, Wiernik P, Devita V. The current status of NCI trials in Hodgkin’s disease. 1985, 293-298. DOI: 10.1007/978-1-4613-2607-6_30.
- Treatment of diffuse large cell non-Hodgkin’s lymphomasFisher R, Devita V, Longo D, Ihde D, Young R. Treatment of diffuse large cell non-Hodgkin’s lymphomas. 1985, 465-469. DOI: 10.1007/978-1-4613-2607-6_49.
- BCVPP chemotherapy for advanced Hodgkin's disease: evidence for greater duration of complete remission, greater survival, and less toxicity than with a MOPP regimen. Results of the Eastern Cooperative Oncology Group study.Bakemeier R, Anderson J, Costello W, Rosner G, Horton J, Glick J, Hines J, Berard C, DeVita V. BCVPP chemotherapy for advanced Hodgkin's disease: evidence for greater duration of complete remission, greater survival, and less toxicity than with a MOPP regimen. Results of the Eastern Cooperative Oncology Group study. Annals Of Internal Medicine 1984, 101: 447-56. PMID: 6089632, DOI: 10.7326/0003-4819-101-4-447.
- Governance of science at the National Cancer Institute: perceptions and opportunities in oncogene research.Fischinger P, DeVita V. Governance of science at the National Cancer Institute: perceptions and opportunities in oncogene research. Cancer Research 1984, 44: 4693-6. PMID: 6467222.
- Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience.Tester W, Kinsella T, Waller B, Makuch R, Kelley P, Glatstein E, DeVita V. Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience. Journal Of Clinical Oncology 1984, 2: 762-9. PMID: 6547479, DOI: 10.1200/jco.1984.2.7.762.
- Prolonged initial remission in patients with nodular mixed lymphoma.Longo D, Young R, Hubbard S, Wesley M, Fisher R, Jaffe E, Berard C, DeVita V. Prolonged initial remission in patients with nodular mixed lymphoma. Annals Of Internal Medicine 1984, 100: 651-6. PMID: 6370065, DOI: 10.7326/0003-4819-100-5-651.
- NIH conference. T-cell lymphoproliferative syndrome associated with human T-cell leukemia/lymphoma virus.Broder S, Bunn P, Jaffe E, Blattner W, Gallo R, Wong-Staal F, Waldmann T, DeVita V. NIH conference. T-cell lymphoproliferative syndrome associated with human T-cell leukemia/lymphoma virus. Annals Of Internal Medicine 1984, 100: 543-57. PMID: 6322632, DOI: 10.7326/0003-4819-100-4-543.
- On special initiatives, critics, and the National Cancer Program.DeVita V. On special initiatives, critics, and the National Cancer Program. Journal Of The National Cancer Institute 1984, 68: 1-4. PMID: 6692421.
- Contrasting viewpoints on cancer drug development: the Wooldridge and Richardson reports.DeVita V. Contrasting viewpoints on cancer drug development: the Wooldridge and Richardson reports. Journal Of The National Cancer Institute 1984, 68: 339-40. PMID: 6692433.
- 25 THERAPEUTIC RESEARCH IN THE NATIONAL CANCER INSTITUTEDeVita V, Goidin A. 25 THERAPEUTIC RESEARCH IN THE NATIONAL CANCER INSTITUTE. 1984, 499-526. DOI: 10.1016/b978-0-12-667980-9.50032-4.
- Governance of science at the national cancer institute: management of resources in an era of scarcity.DeVita V. Governance of science at the national cancer institute: management of resources in an era of scarcity. Cancer Research 1983, 43: 6106-8. PMID: 6640550.
- The governance of science at the National Cancer Institute: a perspective on misperceptions.DeVita V. The governance of science at the National Cancer Institute: a perspective on misperceptions. Cancer Research 1983, 43: 3969-73. PMID: 6407753.
- Charles Heidelberger 1920–1983DeVita V. Charles Heidelberger 1920–1983. Journal Of The National Cancer Institute 1983, 71: 225-225. DOI: 10.1093/jnci/71.2.225.
- Progress in cancer management. Keynote addressDevita V. Progress in cancer management. Keynote address. Cancer 1983, 51: 2401-2409. PMID: 6342749, DOI: 10.1002/1097-0142(19830615)51:12+<2401::aid-cncr2820511302>3.0.co;2-7.
- Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphoma.Greene M, Young R, Merrill J, DeVita V. Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphoma. Cancer Research 1983, 43: 1891-8. PMID: 6572558.
- The Cancer Series: An IntroductionDevita V. The Cancer Series: An Introduction. Hospital Practice 1983, 18: 15-19. PMID: 6404774, DOI: 10.1080/21548331.1983.11702504.
- The james ewing lecture. The relationship between tumor mass and resistance to chemotherapy. Implications for surgical adjuvant treatment of cancerDevita V. The james ewing lecture. The relationship between tumor mass and resistance to chemotherapy. Implications for surgical adjuvant treatment of cancer. Cancer 1983, 51: 1209-1220. PMID: 6825044, DOI: 10.1002/1097-0142(19830401)51:7<1209::aid-cncr2820510707>3.0.co;2-j.
- Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy.Fisher R, DeVita V, Hubbard S, Longo D, Wesley R, Chabner B, Young R. Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy. Annals Of Internal Medicine 1983, 98: 304-9. PMID: 6600902, DOI: 10.7326/0003-4819-98-3-304.
- Cancer prevention NCI's primary goal.Devita V. Cancer prevention NCI's primary goal. U.S. Medicine 1983, 19: 77-8. PMID: 10259324.
- The cure of Hodgkin's disease with drugs.DeVita V, Hubbard S, Moxley J. The cure of Hodgkin's disease with drugs. Advances In Internal Medicine 1983, 28: 277-302. PMID: 6188346.
- Advances in cancer therapeutics: chemotherapy.DeVita V. Advances in cancer therapeutics: chemotherapy. Progress In Clinical And Biological Research 1983, 132A: 47-69. PMID: 6634746.
- Malignant lymphoma I. The histology and staging of 473 patients at the national cancer instituteAnderson T, Chabner B, Young R, Berard C, Garvin AJ, Simon R, Devita V. Malignant lymphoma I. The histology and staging of 473 patients at the national cancer institute. Cancer 1982, 50: 2699-2707. PMID: 7139563, DOI: 10.1002/1097-0142(19821215)50:12<2699::aid-cncr2820501202>3.0.co;2-a.
- Malignant lymphoma II. Prognostic factors and response to treatment of 473 patients at the national cancer instituteAnderson T, Devita V, Simon R, Berard C, Canellos G, Garvin A, Young R. Malignant lymphoma II. Prognostic factors and response to treatment of 473 patients at the national cancer institute. Cancer 1982, 50: 2708-2721. PMID: 7139564, DOI: 10.1002/1097-0142(19821215)50:12<2708::aid-cncr2820501203>3.0.co;2-g.
- Undifferentiated non‐Hodgkin'S lymphomas (Burkitt's and non‐Burkitt's types). The relevance of making this histologic distinctionMiliauskas J, Berard C, Young R, Garvin A, Edwards B, Devita V. Undifferentiated non‐Hodgkin'S lymphomas (Burkitt's and non‐Burkitt's types). The relevance of making this histologic distinction. Cancer 1982, 50: 2115-2121. PMID: 7127252, DOI: 10.1002/1097-0142(19821115)50:10<2115::aid-cncr2820501024>3.0.co;2-9.
- Immunological and physiological responses to whole-body hyperthermia.Bull J, Lees D, Schuette W, Smith R, Glatstein E, DeVita V. Immunological and physiological responses to whole-body hyperthermia. National Cancer Institute Monograph 1982, 61: 177-81. PMID: 7177176.
- Hodgkin's disease: conference summary and future directions.DeVita V. Hodgkin's disease: conference summary and future directions. Journal Of The National Cancer Institute 1982, 66: 1045-55. PMID: 7074631.
- Chemotherapy for Hodgkin's disease: the remaining challenges.Longo D, Young R, DeVita V. Chemotherapy for Hodgkin's disease: the remaining challenges. Journal Of The National Cancer Institute 1982, 66: 925-36. PMID: 7042091.
- Changing patterns of Hodgkin's disease at autopsy: a 25-year experience at the National Cancer Institute, 1953--1978.Grogan T, Berard C, Steinhorn S, Hankey B, Kant J, Miliauskas J, Young R, DeVita V. Changing patterns of Hodgkin's disease at autopsy: a 25-year experience at the National Cancer Institute, 1953--1978. Journal Of The National Cancer Institute 1982, 66: 653-65. PMID: 7074636.
- Histologic progression in non-Hodgkin's lymphoma.Hubbard S, Chabner B, DeVita V, Simon R, Berard C, Jones R, Garvin A, Canellos G, Osborne C, Young R. Histologic progression in non-Hodgkin's lymphoma. Blood 1982, 59: 258-64. PMID: 7034812, DOI: 10.1182/blood.v59.2.258.bloodjournal592258.
- Histologic Progression in Non-Hodgkin’s LymphomaHubbard S, Chabner B, DeVita V, Simon R, Berard C, Jones R, Garvin A, Canellos G, Osborne C, Young R. Histologic Progression in Non-Hodgkin’s Lymphoma. Blood 1982, 59: 258-264. DOI: 10.1182/blood.v59.2.258.258.
- DeVita responds to Post article.DeVita V. DeVita responds to Post article. Historical Washington Post 1981, a27. PMID: 11646113.
- Long-term follow-up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's diseaseSchilsky R, Sherins R, Hubbard S, Wesley M, Young R, DeVita V. Long-term follow-up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's disease. The American Journal Of Medicine 1981, 71: 552-556. PMID: 7282743, DOI: 10.1016/0002-9343(81)90205-9.
- Factors predicting long-term survival in diffuse mixed, histiocytic, or undifferentiated lymphoma.Fisher R, Hubbard S, DeVita V, Berard C, Wesley R, Cossman J, Young R. Factors predicting long-term survival in diffuse mixed, histiocytic, or undifferentiated lymphoma. Blood 1981, 58: 45-51. PMID: 7236892, DOI: 10.1182/blood.v58.1.45.bloodjournal58145.
- Factors Predicting Long-Term Survival in Diffuse Mixed, Histiocytic, or Undifferentiated LymphomaFisher R, Hubbard S, DeVita V, Berard C, Wesley R, Cossman J, Young R. Factors Predicting Long-Term Survival in Diffuse Mixed, Histiocytic, or Undifferentiated Lymphoma. Blood 1981, 58: 45-51. DOI: 10.1182/blood.v58.1.45.45.
- Natural history of malignant lymphomas with divergent histologies at staging evaluationFisher R, Jones R, Devita V, Simon R, Garvin A, Berard C, Young R. Natural history of malignant lymphomas with divergent histologies at staging evaluation. Cancer 1981, 47: 2022-2025. PMID: 7226096, DOI: 10.1002/1097-0142(19810415)47:8<2022::aid-cncr2820470820>3.0.co;2-v.
- Multimodal treatment of primary breast carcinoma Analysis of accomplishments and problem areasWeiss R, Henney J, DeVita V. Multimodal treatment of primary breast carcinoma Analysis of accomplishments and problem areas. The American Journal Of Medicine 1981, 70: 844-851. PMID: 7011024, DOI: 10.1016/0002-9343(81)90541-6.
- Current results of the screening program at the division of cancer treatment, national cancer instituteGoldin A, Venditti J, Macdonald J, Muggia F, Henney J, Devita V. Current results of the screening program at the division of cancer treatment, national cancer institute. European Journal Of Cancer 1981, 17: 129-142. PMID: 6894902, DOI: 10.1016/0014-2964(81)90027-x.
- Animal toxicology for early clinical trials with anticancer agents.Rozencweig M, Von Hoff D, Staquet M, Schein P, Penta J, Goldin A, Muggia F, Freireich E, DeVita V. Animal toxicology for early clinical trials with anticancer agents. American Journal Of Clinical Oncology 1981, 4: 21-8. PMID: 6783332.
- Resolution of longstanding protein-losing enteropathy in a patient with intestinal lymphangiectasia after treatment for malignant lymphomaBroder S, Callihan T, Jaffe E, DeVita V, Strober W, Bartter F, Waldmann T. Resolution of longstanding protein-losing enteropathy in a patient with intestinal lymphangiectasia after treatment for malignant lymphoma. Gastroenterology 1981, 80: 166-168. PMID: 7450403, DOI: 10.1016/0016-5085(81)90208-0.
- High-volume intraperitoneal chemotherapy with methotrexate in patients with cancer.Jones R, Collins J, Myers C, Brooks A, Hubbard S, Balow J, Brennan M, Dedrick R, DeVita V. High-volume intraperitoneal chemotherapy with methotrexate in patients with cancer. Cancer Research 1981, 41: 55-9. PMID: 7448776.
- Erythrocyte osmotic fragility in patients receiving hyperthermia with and without chemotherapy.Whang-Peng J, Lees D, Schuette W, Smith R, Bull J, DeVita V. Erythrocyte osmotic fragility in patients receiving hyperthermia with and without chemotherapy. Journal Of The National Cancer Institute 1981, 65: 1103-4. PMID: 7296555.
- The consequences of the chemotherapy of Hodgkin's disease: The 10th David A. Karnofsky memorial lectureDevita V. The consequences of the chemotherapy of Hodgkin's disease: The 10th David A. Karnofsky memorial lecture. Cancer 1981, 47: 1-13. PMID: 6970069, DOI: 10.1002/1097-0142(19810101)47:1<1::aid-cncr2820470102>3.0.co;2-2.
- Non-Hodgkin's lymphomas in leukemic phase: Clinicopathologic correlationsCome S, Jaffe E, Andersen J, Mann R, Johnson B, DeVita V, Young R. Non-Hodgkin's lymphomas in leukemic phase: Clinicopathologic correlations. The American Journal Of Medicine 1980, 69: 667-674. PMID: 7001897, DOI: 10.1016/0002-9343(80)90416-7.
- The Rappaport classification of non-Hodgkin's lymphomas: a closer look using other proposed classifications.Garvin A, Simon R, Young R, DeVita V, Berard C. The Rappaport classification of non-Hodgkin's lymphomas: a closer look using other proposed classifications. Seminars In Oncology 1980, 7: 234-43. PMID: 6998002.
- Staging of non-Hodgkin's lymphoma.Chabner B, Fisher R, Young R, DeVita V. Staging of non-Hodgkin's lymphoma. Seminars In Oncology 1980, 7: 285-91. PMID: 7414341.
- The evolution of primary multimodality treatment in resectable breast cancerHenney J, Devita V. The evolution of primary multimodality treatment in resectable breast cancer. Cancer 1980, 46: 999-1008. PMID: 6994877, DOI: 10.1002/1097-0142(19800815)46:4+<999::aid-cncr2820461325>3.0.co;2-e.
- Nodular Histiocytic Lymphoma: An Aggressive Nodular Lymphoma With Potential for Prolonged Disease-Free SurvivalOsborne C, Norton L, Young R, Garvin A, Simon R, Berard C, Hubbard S, DeVita V. Nodular Histiocytic Lymphoma: An Aggressive Nodular Lymphoma With Potential for Prolonged Disease-Free Survival. Blood 1980, 56: 98-103. DOI: 10.1182/blood.v56.1.98.98.
- Nodular histiocytic lymphoma: an aggressive nodular lymphoma with potential for prolonged disease-free survival.Osborne C, Norton L, Young R, Garvin A, Simon R, Berard C, Hubbard S, DeVita V. Nodular histiocytic lymphoma: an aggressive nodular lymphoma with potential for prolonged disease-free survival. Blood 1980, 56: 98-103. PMID: 6992889, DOI: 10.1182/blood.v56.1.98.bloodjournal56198.
- IARC monographs on the evaluation of carcinogenic risk of chemicals to humans.Higginson J, DeVita V. IARC monographs on the evaluation of carcinogenic risk of chemicals to humans. AIHA Journal 1980, 41: a26, a28, a30 passim. PMID: 6998267.
- Persistent immunologic abnormalities in long-term survivors of advanced Hodgkin's disease.Fisher R, DeVita V, Bostick F, Vanhaelen C, Howser D, Hubbard S, Young R. Persistent immunologic abnormalities in long-term survivors of advanced Hodgkin's disease. Annals Of Internal Medicine 1980, 92: 595-9. PMID: 6992672, DOI: 10.7326/0003-4819-92-5-595.
- Cancer, the Curable DiseasesDeVita V, Kershner L. Cancer, the Curable Diseases. Journal Of The American Pharmacists Association 1980, 20: 16-22. PMID: 6155779, DOI: 10.1016/s0160-3450(15)32990-1.
- Phase I and pharmacological studies of 5-fluorouracil administered intraperitoneally.Speyer J, Collins J, Dedrick R, Brennan M, Buckpitt A, Londer H, DeVita V, Myers C. Phase I and pharmacological studies of 5-fluorouracil administered intraperitoneally. Cancer Research 1980, 40: 567-72. PMID: 7471076.
- Advances in the multimodal primary management of cancer.DeVita V, Henney J, Weiss R. Advances in the multimodal primary management of cancer. Advances In Internal Medicine 1980, 26: 115-29. PMID: 7013437.
- General Progress in Clinical Chemotherapy of Advanced DiseaseMuggia F, Henney J, DeVita V. General Progress in Clinical Chemotherapy of Advanced Disease. 1980, 74: 1-7. PMID: 7003657, DOI: 10.1007/978-3-642-81488-4_1.
- Human models of human diseases; breast cancer and the lymphomasDevita V. Human models of human diseases; breast cancer and the lymphomas. International Journal Of Radiation Oncology • Biology • Physics 1979, 5: 1855-1867. PMID: 393666, DOI: 10.1016/0360-3016(79)90571-6.
- Chemotherapy of Hodgkin's diseaseYoung R, DeVita V. Chemotherapy of Hodgkin's disease. Clinics In Haematology 1979, 8: 625-644. PMID: 91466, DOI: 10.1016/s0308-2261(79)80007-7.
- The dilemma regarding postoperative chemotherapy in primary carcinoma of the colon.Weiss R, DeVita V. The dilemma regarding postoperative chemotherapy in primary carcinoma of the colon. Journal Of The American College Of Surgeons 1979, 149: 267-71. PMID: 380029.
- Multimodal primary cancer treatment (adjuvant chemotherapy): current results and future prospects.Weiss R, DeVita V. Multimodal primary cancer treatment (adjuvant chemotherapy): current results and future prospects. Annals Of Internal Medicine 1979, 91: 251-60. PMID: 380437, DOI: 10.7326/0003-4819-91-2-251.
- A comparison between combination chemotherapy and total body irradiation plus combination chemotherapy in non‐Hodgkin's lymphomaBrereton H, Young R, Longo D, Kirkland L, Berard C, Jaffe E, Devita V, Johnson R. A comparison between combination chemotherapy and total body irradiation plus combination chemotherapy in non‐Hodgkin's lymphoma. Cancer 1979, 43: 2227-2231. PMID: 378350, DOI: 10.1002/1097-0142(197906)43:6<2227::aid-cncr2820430611>3.0.co;2-j.
- The role of combined modality therapy in the treatment of stage IIIA Hodgkin's diseaseDevita V. The role of combined modality therapy in the treatment of stage IIIA Hodgkin's disease. International Journal Of Radiation Oncology • Biology • Physics 1979, 5: 913. PMID: 500419, DOI: 10.1016/0360-3016(79)90077-4.
- Treatment of refractory splenomegaly in myeloproliferative disease by splenic artery infusion.Canellos G, Sutliffe S, DeVita V, Lister T. Treatment of refractory splenomegaly in myeloproliferative disease by splenic artery infusion. Blood 1979, 53: 1014-7. PMID: 435637, DOI: 10.1182/blood.v53.5.1014.bloodjournal5351014.
- Prolonged disease-free survival in Hodgkin's disease with MOPP reinduction after first relapse.Fisher R, DeVita V, Hubbard S, Simon R, Young R. Prolonged disease-free survival in Hodgkin's disease with MOPP reinduction after first relapse. Annals Of Internal Medicine 1979, 90: 761-3. PMID: 434676, DOI: 10.7326/0003-4819-90-5-761.
- Clinical characteristics of Pneumocystis carinii pneumonia.Geelhoed G, Hubbard S, Powell R, Doppman J, DeVita V. Clinical characteristics of Pneumocystis carinii pneumonia. The American Surgeon 1979, 45: 293-304. PMID: 313176.
- Treatment of Refractory Splenomegaly in Myeloproliferative Disease by Splenic Artery InfusionCanellos G, Sutliffe S, DeVita V, Lister T. Treatment of Refractory Splenomegaly in Myeloproliferative Disease by Splenic Artery Infusion. Blood 1979, 53: 1014-1017. DOI: 10.1182/blood.v53.5.1014.1014.
- Advanced Ovarian Adenocarcinoma A Prospective Clinical Trial of Melphalan (L-PAM) Versus Combination ChemotherapyYoung R, Chabner B, Hubbard S, Fisher R, Bender R, Anderson T, Simon R, Canellos G, Devita V. Advanced Ovarian Adenocarcinoma A Prospective Clinical Trial of Melphalan (L-PAM) Versus Combination Chemotherapy. Obstetrical & Gynecological Survey 1979, 34: 414. DOI: 10.1097/00006254-197905000-00027.
- Whole body hyperthermia: a phase-I trial of a potential adjuvant to chemotherapy.Bull J, Lees D, Schuette W, Whang-Peng J, Smith R, Bynum G, Atkinson E, Gottdiener J, Gralnick H, Shawker T, DeVita V. Whole body hyperthermia: a phase-I trial of a potential adjuvant to chemotherapy. Annals Of Internal Medicine 1979, 90: 317-23. PMID: 426399, DOI: 10.7326/0003-4819-90-3-317.
- Central nervous system complications of non-Hodgkin's lymphoma The potential role for prophylactic therapyYoung R, Howser D, Anderson T, Fisher R, Jaffe E, DeVita V. Central nervous system complications of non-Hodgkin's lymphoma The potential role for prophylactic therapy. The American Journal Of Medicine 1979, 66: 435-443. PMID: 433950, DOI: 10.1016/0002-9343(79)91065-9.
- Combination chemotherapy of acute leukemia and lymphomaLewis B, DeVita V. Combination chemotherapy of acute leukemia and lymphoma. Pharmacology & Therapeutics 1979, 7: 91-121. PMID: 392552, DOI: 10.1016/0163-7258(79)90026-3.
- CNS Infiltration: A Complication of Diffuse LymphomasYoung R, Howser D, Anderson T, Jaffe E, DeVita V. CNS Infiltration: A Complication of Diffuse Lymphomas. 1979, 121-130. DOI: 10.1007/978-1-349-04285-2_11.
- Clinical Relevance of the Histopathological Subclassification of Diffuse Histiocytic LymphomaStrauchen J, Young R, Devita V, Anderson T, Fantone J, Berard C. Clinical Relevance of the Histopathological Subclassification of Diffuse Histiocytic Lymphoma. New England Journal Of Medicine 1978, 299: 1382-1387. PMID: 362206, DOI: 10.1056/nejm197812212992503.
- Advanced Ovarian Adenocarcinoma — A Prospective Clinical Trial of Melphalan (L-PAM) versus Combination ChemotherapyYoung R, Chabner B, Hubbard S, Fisher R, Bender R, Anderson T, Simon R, Canellos G, DeVita V. Advanced Ovarian Adenocarcinoma — A Prospective Clinical Trial of Melphalan (L-PAM) versus Combination Chemotherapy. New England Journal Of Medicine 1978, 299: 1261-1266. PMID: 101843, DOI: 10.1056/nejm197812072992301.
- Hodgkin's Disease: An OverviewLEWIS B, DeVITA V. Hodgkin's Disease: An Overview. Southern Medical Journal 1978, 71: 1546-1552. PMID: 83007, DOI: 10.1097/00007611-197812000-00029.
- Future prospectives in the treatment of breast cancer.Henney J, DeVita V. Future prospectives in the treatment of breast cancer. Seminars In Oncology 1978, 5: 465-8. PMID: 366758.
- Hexamethylmelamine in alkylating agent‐resistant ovarian carcinomaJohnson B, Fisher R, Bender R, Devita V, Chabner B, Young R. Hexamethylmelamine in alkylating agent‐resistant ovarian carcinoma. Cancer 1978, 42: 2157-2161. PMID: 102417, DOI: 10.1002/1097-0142(197811)42:5<2157::aid-cncr2820420511>3.0.co;2-7.
- Book ReviewDevita V. Book Review. New England Journal Of Medicine 1978, 299: 963-963. DOI: 10.1056/nejm197810262991731.
- Combination therapy of the lymphomas.Lewis B, DeVita V. Combination therapy of the lymphomas. Seminars In Hematology 1978, 15: 431-57. PMID: 366762.
- High volume intraperitoneal chemotherapy (“Belly bath”) for ovarian cancerJones R, Myers C, Guarino A, Dedrick R, Hubbard S, DeVita V. High volume intraperitoneal chemotherapy (“Belly bath”) for ovarian cancer. Cancer Chemotherapy And Pharmacology 1978, 1: 161-166. PMID: 373916, DOI: 10.1007/bf00253116.
- Sequential nonsurgical and surgical staging of non‐Hodgkin's lymphomaChabner B, Johnson R, Young R, Canellos G, Hubbard S, Johnson S, Devita V. Sequential nonsurgical and surgical staging of non‐Hodgkin's lymphoma. Cancer 1978, 42: 922-925. PMID: 150938, DOI: 10.1002/1097-0142(197808)42:2+<922::aid-cncr2820420714>3.0.co;2-9.
- Patterns of relapse in advanced Hodgkin's disease treated with combination chemotherapyYoung R, Canellos G, Chabner B, Hubbard S, Devita V. Patterns of relapse in advanced Hodgkin's disease treated with combination chemotherapy. Cancer 1978, 42: 1001-1007. PMID: 688174, DOI: 10.1002/1097-0142(197808)42:2+<1001::aid-cncr2820420723>3.0.co;2-z.
- The chemotherapy of Hodgkin's disease. Past experiences and future directionsDevita V, Lewis B, Rozencweig M, Muggia F. The chemotherapy of Hodgkin's disease. Past experiences and future directions. Cancer 1978, 42: 979-990. PMID: 356960, DOI: 10.1002/1097-0142(197808)42:2+<979::aid-cncr2820420721>3.0.co;2-s.
- Diffuse histiocytic lymphoma involving the gastrointestinal tractHande K, Fisher R, Devita V, Chabner B, Young R. Diffuse histiocytic lymphoma involving the gastrointestinal tract. Cancer 1978, 41: 1984-1989. PMID: 348299, DOI: 10.1002/1097-0142(197805)41:5<1984::aid-cncr2820410544>3.0.co;2-8.
- The Evolution of Therapeutic Research in CancerDeVita V. The Evolution of Therapeutic Research in Cancer. New England Journal Of Medicine 1978, 298: 907-910. PMID: 634335, DOI: 10.1056/nejm197804202981610.
- Randomized comparison of chemotherapy (CVP) and radiotherapy (TBI) in stage III–IV poorly differentiated lymphocytic lymphomaJohnson R, Canellos G, Young R, Chabner B, DeVita V. Randomized comparison of chemotherapy (CVP) and radiotherapy (TBI) in stage III–IV poorly differentiated lymphocytic lymphoma. International Journal Of Radiation Oncology • Biology • Physics 1978, 4: 33. DOI: 10.1016/0360-3016(78)90617-x.
- Chemotherapy (cyclophosphamide, vincristine, and prednisone) versus radiotherapy (total body irradiation) for stage III-IV poorly differentiated lymphocytic lymphoma.Johnson R, Canellos G, Young R, Chabner B, DeVita V. Chemotherapy (cyclophosphamide, vincristine, and prednisone) versus radiotherapy (total body irradiation) for stage III-IV poorly differentiated lymphocytic lymphoma. Journal Of The National Cancer Institute 1978, 62: 321-5. PMID: 580598.
- Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer.Dedrick R, Myers C, Bungay P, DeVita V. Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Journal Of The National Cancer Institute 1978, 62: 1-11. PMID: 626987.
- New Anticancer DrugsMuggia F, Bono V, DeVita V. New Anticancer Drugs. 1978, 23: 42-49. PMID: 646328, DOI: 10.1159/000401470.
- Letter to the editorMuggia F, Devita V. Letter to the editor. Pediatric Blood & Cancer 1978, 4: 181-181. PMID: 661754, DOI: 10.1002/mpo.2950040215.
- Invited commentaryDeVita V. Invited commentary. World Journal Of Surgery 1978, 2: 105-107. DOI: 10.1007/bf01574474.
- Risk of new cancers in patients with Hodgkin's diseaseArseneau J, Canellos G, Johnson R, Devita V. Risk of new cancers in patients with Hodgkin's disease. Cancer 1977, 40: 1912-1916. PMID: 907993, DOI: 10.1002/1097-0142(197710)40:4+<1912::aid-cncr2820400823>3.0.co;2-d.
- Combination chemotherapy in non-Hodgkin's lymphoma: results of long-term followup.Anderson T, Bender R, Fisher R, DeVita V, Chabner B, Berard C, Norton L, Young R. Combination chemotherapy in non-Hodgkin's lymphoma: results of long-term followup. Journal Of The National Cancer Institute 1977, 61: 1057-66. PMID: 71205.
- Proceedings of the Conference on non-Hodgkin's lymphomas: summary of symposium.DeVita V. Proceedings of the Conference on non-Hodgkin's lymphomas: summary of symposium. Journal Of The National Cancer Institute 1977, 61: 1223-7. PMID: 332356.
- Sequential staging in non-Hodgkin's lymphoma.Chabner B, Johnson R, DeVita V, Canellos G, Hubbard S, Johnson S, Young R. Sequential staging in non-Hodgkin's lymphoma. Journal Of The National Cancer Institute 1977, 61: 993-7. PMID: 902262.
- Hodgkin's disease: The salvage of radiation treatment failuresDeVita V. Hodgkin's disease: The salvage of radiation treatment failures. International Journal Of Radiation Oncology • Biology • Physics 1977, 2: 1035-1037. PMID: 591399, DOI: 10.1016/0360-3016(77)90208-5.
- Peritoneoscopy: a technique to evaluate therapeutic efficacy in non-Hodgkin's lymphoma patients.Anderson T, Bender R, Rosenoff S, Brereton H, Chabner B, DeVita V, Hubbard S, Young R. Peritoneoscopy: a technique to evaluate therapeutic efficacy in non-Hodgkin's lymphoma patients. Journal Of The National Cancer Institute 1977, 61: 1017-22. PMID: 143345.
- Advanced lymphocytic lymphoma: randomized comparisons of chemotherapy and radiotherapy, alone or in combination.Young R, Johnson R, Canellos G, Chabner B, Brereton H, Berard C, DeVita V. Advanced lymphocytic lymphoma: randomized comparisons of chemotherapy and radiotherapy, alone or in combination. Journal Of The National Cancer Institute 1977, 61: 1153-9. PMID: 332349.
- Malignant melanoma: prognostic factors and therapeutic results.DeVita V, Fisher R. Malignant melanoma: prognostic factors and therapeutic results. West Virginia Medical Journal 1977, 73: 167-72. PMID: 268079.
- Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapyFisher R, DeVita V, Johnson B, Simon R, Young R. Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy. The American Journal Of Medicine 1977, 63: 177-182. PMID: 70170, DOI: 10.1016/0002-9343(77)90230-3.
- Characteristics of Blast Crisis in Chronic Granulocytic LeukemiaRosenthal S, Canellos G, DeVita V, Gralnick H. Characteristics of Blast Crisis in Chronic Granulocytic Leukemia. Blood 1977, 49: 705-714. DOI: 10.1182/blood.v49.5.705.705.
- Characteristics of blast crisis in chronic granulocytic leukemia.Rosenthal S, Canellos G, DeVita V, Gralnick H. Characteristics of blast crisis in chronic granulocytic leukemia. Blood 1977, 49: 705-14. PMID: 265737, DOI: 10.1182/blood.v49.5.705.bloodjournal495705.
- The treatment of Hodgkin's diseaseYoung R, Anderson T, DeVita V. The treatment of Hodgkin's disease. Current Problems In Cancer 1977, 1: 1-29. PMID: 66119, DOI: 10.1016/s0147-0272(77)80009-3.
- Combined modality treatment of American Burkittapos;s lymphomaZiegler J, Devita V, Graw R, Herzig G, Leventhal B, Levine A, Pomeroy T. Combined modality treatment of American Burkittapos;s lymphoma. Cancer 1976, 38: 2225-2231. PMID: 1036716, DOI: 10.1002/1097-0142(197612)38:6<2225::aid-cncr2820380606>3.0.co;2-f.
- Treatment of Pneumocystis carinii pneumonia: current status of the regimens of pentamidine isethionate and pyrimethamine-sulfadiazine.Young R, DeVita V. Treatment of Pneumocystis carinii pneumonia: current status of the regimens of pentamidine isethionate and pyrimethamine-sulfadiazine. National Cancer Institute Monograph 1976, 43: 193-200. PMID: 1087955.
- Pneumocystis pneumonia in patients with cancer: clinical setting.DeVita V, Goodell B, Hubbard S, Geelhoed G, Young R. Pneumocystis pneumonia in patients with cancer: clinical setting. National Cancer Institute Monograph 1976, 43: 41-7. PMID: 1087959.
- Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma.Schein P, DeVita V, Hubbard S, Chabner B, Canellos G, Berard C, Young R. Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma. Annals Of Internal Medicine 1976, 85: 417-22. PMID: 61732, DOI: 10.7326/0003-4819-85-4-417.
- A Phase I–II Trial of Multiple-Dose Polyriboinosinic-Polyribocytidylic Acid in Patients With Leukemia or Solid TumorsRobinson R, DeVita V, Levy H, Baron S, Hubbard S, Levine A. A Phase I–II Trial of Multiple-Dose Polyriboinosinic-Polyribocytidylic Acid in Patients With Leukemia or Solid Tumors. Journal Of The National Cancer Institute 1976, 57: 599-602. PMID: 978771, DOI: 10.1093/jnci/57.3.599.
- Sequential nonsurgical and surgical staging of non-Hodgkin's lymphoma.Chabner B, Johnson R, Young R, Canellos G, Hubbard S, Johnson S, DeVita V. Sequential nonsurgical and surgical staging of non-Hodgkin's lymphoma. Annals Of Internal Medicine 1976, 85: 149-54. PMID: 782309, DOI: 10.7326/0003-4819-85-2-149.
- Carcinoma of the Breast: Status of Adjuvant Medical TreatmentDeVita V. Carcinoma of the Breast: Status of Adjuvant Medical Treatment. 1976, 11: 42-58. DOI: 10.1159/000399362.
- Perspectives on research in gynecologic oncology. Treatment protocolsDevita V, Wasserman T, Young R, Carter S. Perspectives on research in gynecologic oncology. Treatment protocols. Cancer 1976, 38: 509-525. PMID: 776390, DOI: 10.1002/1097-0142(197607)38:1<509::aid-cncr2820380175>3.0.co;2-a.
- Treatment of hodgkin's disease using intensive chemotherapy followed by irradiationKun L, Devita V, Young R, Johnson R. Treatment of hodgkin's disease using intensive chemotherapy followed by irradiation. International Journal Of Radiation Oncology • Biology • Physics 1976, 1: 619-626. PMID: 824248, DOI: 10.1016/0360-3016(76)90143-7.
- Chemotherapy of the Blastic Phase of Chronic Granulocytic Leukemia: Hypodiploidy and Response to TherapyCanellos G, DeVita V, Whang-Peng J, Chabner B, Schein P, Young R. Chemotherapy of the Blastic Phase of Chronic Granulocytic Leukemia: Hypodiploidy and Response to Therapy. Blood 1976, 47: 1003-1009. DOI: 10.1182/blood.v47.6.1003.1003.
- Chemotherapy of the blastic phase of chronic granulocytic leukemia: hypodiploidy and response to therapy.Canellos G, DeVita V, Whang-Peng J, Chabner B, Schein P, Young R. Chemotherapy of the blastic phase of chronic granulocytic leukemia: hypodiploidy and response to therapy. Blood 1976, 47: 1003-9. PMID: 1064434, DOI: 10.1182/blood.v47.6.1003.bloodjournal4761003.
- Letter: Laparoscopy and laparotomy in staging of Hodgkin's disease.DeVita V. Letter: Laparoscopy and laparotomy in staging of Hodgkin's disease. The BMJ 1976, 1: 831. PMID: 130958, PMCID: PMC1639501, DOI: 10.1136/bmj.1.6013.831-b.
- CHEMOTHERAPYHUBBARD S, DEVITA V. CHEMOTHERAPY. American Journal Of Nursing 1976, 76: 560-565. DOI: 10.1097/00000446-197604000-00018.
- Chemotherapy research nurse.Hubbard S, Devita V. Chemotherapy research nurse. American Journal Of Nursing 1976, 76: 560-5. PMID: 818899, DOI: 10.2307/3423770.
- Combination chemotherapy for advanced breast cancer: response and effect on survival.Canellos G, DeVita V, Gold G, Chabner B, Schein P, Young R. Combination chemotherapy for advanced breast cancer: response and effect on survival. Annals Of Internal Medicine 1976, 84: 389-92. PMID: 1259283, DOI: 10.7326/0003-4819-84-4-389.
- Pneumocystis PneumoniaMICHAELIS L, LEIGHT G, POWELL R, DEVITA V. Pneumocystis Pneumonia. Annals Of Surgery 1976, 183: 301-306. PMID: 1083218, PMCID: PMC1344242, DOI: 10.1097/00000658-197603000-00016.
- Natural history of malignant melanoma as related to therapy.DeVita V, Fisher R. Natural history of malignant melanoma as related to therapy. Journal Of The National Cancer Institute 1976, 60: 153-7. PMID: 1260773.
- Effect of splenectomy on tolerance to combination chemotherapy in patients with lymphoma.Ihde D, DeVita V, Canellos G, Young R. Effect of splenectomy on tolerance to combination chemotherapy in patients with lymphoma. Blood 1976, 47: 211-22. PMID: 1244920, DOI: 10.1182/blood.v47.2.211.bloodjournal472211.
- Effect of Splenectomy on Tolerance to Combination Chemotherapy in Patients With LymphomaIhde D, DeVita V, Canellos G, Young R. Effect of Splenectomy on Tolerance to Combination Chemotherapy in Patients With Lymphoma. Blood 1976, 47: 211-222. DOI: 10.1182/blood.v47.2.211.211.
- Central nervous system complications in patients with diffuse histiocytic and undifferentiated lymphoma: leukemia revisited.Bunn P, Schein P, Banks P, DeVita V. Central nervous system complications in patients with diffuse histiocytic and undifferentiated lymphoma: leukemia revisited. Blood 1976, 47: 3-10. PMID: 1106798, DOI: 10.1182/blood.v47.1.3.bloodjournal4713.
- Splenectomy in the chronic phase of chronic granulocytic leukemia. Effects in 32 patients.Ihde D, Canellos G, Schwartz J, DeVita V. Splenectomy in the chronic phase of chronic granulocytic leukemia. Effects in 32 patients. Annals Of Internal Medicine 1976, 84: 17-21. PMID: 1060395, DOI: 10.7326/0003-4819-84-1-17.
- Central Nervous System Complications in Patients With Diffuse Histiocytic and Undifferentiated Lymphoma: Leukemia RevisitedBunn P, Schein P, Banks P, DeVita V. Central Nervous System Complications in Patients With Diffuse Histiocytic and Undifferentiated Lymphoma: Leukemia Revisited. Blood 1976, 47: 3-10. DOI: 10.1182/blood.v47.1.3.3.
- Pathological staging of 100 consecutive untreated patients with non‐Hodgkin's lymphomas. Extramedullary sites of diseaseLotz M, Chabner B, Devita V, Johnson R, Berard C. Pathological staging of 100 consecutive untreated patients with non‐Hodgkin's lymphomas. Extramedullary sites of disease. Cancer 1976, 37: 266-270. PMID: 1247961, DOI: 10.1002/1097-0142(197601)37:1<266::aid-cncr2820370136>3.0.co;2-z.
- Meningeal leukemia in the blastic phase of chronic granulocytic leukemiaSchwartz J, Canellos G, Young R, DeVita V. Meningeal leukemia in the blastic phase of chronic granulocytic leukemia. The American Journal Of Medicine 1975, 59: 819-828. PMID: 1059328, DOI: 10.1016/0002-9343(75)90467-2.
- Osteonecrosis of the femoral head in patients with lymphoma treated with intermittent combination chemotherapy (including corticosteroids)Ihde D, Devita V. Osteonecrosis of the femoral head in patients with lymphoma treated with intermittent combination chemotherapy (including corticosteroids). Cancer 1975, 36: 1585-1588. PMID: 1192349, DOI: 10.1002/1097-0142(197511)36:5<1585::aid-cncr2820360508>3.0.co;2-d.
- Preliminary Results of trials of chemotherapy in advanced ovarian carcinoma.Young R, Chabner B, Hubbard S, Canellos G, DeVita V. Preliminary Results of trials of chemotherapy in advanced ovarian carcinoma. National Cancer Institute Monograph 1975, 42: 145-8. PMID: 825777.
- Introduction. Ovarian cancer, an enigma wrapped in a puzzle.DeVita V. Introduction. Ovarian cancer, an enigma wrapped in a puzzle. Seminars In Oncology 1975, 2: 189-90. PMID: 1234799.
- High dose intravenous bleomycin in the treatment of advanced lymphomasHubbard S, Chabner B, Canellos G, Young R, DeVita V. High dose intravenous bleomycin in the treatment of advanced lymphomas. European Journal Of Cancer 1975, 11: 623-626. PMID: 56271, DOI: 10.1016/0014-2964(75)90096-1.
- The American Burkitt Lymphoma Registry: a progress report.Levine P, Connelly R, Berard C, O'Connor G, Dorfman R, EASTON J, DeVita V. The American Burkitt Lymphoma Registry: a progress report. Annals Of Internal Medicine 1975, 83: 31-6. PMID: 1147436, DOI: 10.7326/0003-4819-83-1-31.
- Peritoneoscopy: a valuable staging tool in ovarian carcinoma.Rosenoff S, Young R, Anderson T, Bagley C, Chabner B, Schein P, Hubbard S, DeVita V. Peritoneoscopy: a valuable staging tool in ovarian carcinoma. Annals Of Internal Medicine 1975, 83: 37-41. PMID: 125057, DOI: 10.7326/0003-4819-83-1-37.
- In vitro granulocyte production in patients with Hodgkin's disease and lymphocytic, histiocytic, and mixed lymphomas.Bull J, DeVita V, Carbone P. In vitro granulocyte production in patients with Hodgkin's disease and lymphocytic, histiocytic, and mixed lymphomas. Blood 1975, 45: 833-42. PMID: 1125431, DOI: 10.1182/blood.v45.6.833.bloodjournal456833.
- In Vitro Granulocyte Production in Patients With Hodgkin’s Disease and Lymphocytic, Histiocytic, and Mixed LymphomasBull J, DeVita V, Carbone P. In Vitro Granulocyte Production in Patients With Hodgkin’s Disease and Lymphocytic, Histiocytic, and Mixed Lymphomas. Blood 1975, 45: 833-842. DOI: 10.1182/blood.v45.6.833.833.
- Single agent versus combination chemotherapyDeVita V. Single agent versus combination chemotherapy. CA A Cancer Journal For Clinicians 1975, 25: 152-158. PMID: 165865, DOI: 10.3322/canjclin.25.3.152.
- SECOND MALIGNANCIES COMPLICATING HODGKIN'S DISEASE IN REMISSIONCanellos G, Arseneau J, Devita V, Whang-Peng J, Johnson R. SECOND MALIGNANCIES COMPLICATING HODGKIN'S DISEASE IN REMISSION. The Lancet 1975, 305: 947-949. PMID: 48122, DOI: 10.1016/s0140-6736(75)92007-3.
- Therapy of advanced lymphocytic lymphoma a preliminary report of a randomized trial between combination chemotherapy (CVP) and intensive radiotherapy.Canellos G, DeVita V, Young R, Chabner B, Schein P, Johnson R. Therapy of advanced lymphocytic lymphoma a preliminary report of a randomized trial between combination chemotherapy (CVP) and intensive radiotherapy. British Journal Of Cancer. Supplement 1975, 2: 474-80. PMID: 1101933, PMCID: PMC2149565.
- Patterns of involvement with malignant lymphoma and implications for treatment decision making.Johnson R, DeVita V, Kun L, Chabner B, Chretien P, Berard C, Johnson S. Patterns of involvement with malignant lymphoma and implications for treatment decision making. British Journal Of Cancer. Supplement 1975, 2: 237-41. PMID: 1182071, PMCID: PMC2149575.
- Percutaneous liver biopsy, peritoneoscopy and laparotomy: an assessment of relative merits in the lymphomata.Chabner B, Johnson R, Chretien P, Schein P, Young R, Canellos C, Hubbard S, Anderson T, Rosenoff S, DeVita V. Percutaneous liver biopsy, peritoneoscopy and laparotomy: an assessment of relative merits in the lymphomata. British Journal Of Cancer. Supplement 1975, 2: 242-7. PMID: 126693, PMCID: PMC2149568.
- American Burkitt's lymphoma: A clinicopathologic study of 30 cases I. Clinical factors relating to prolonged survivalArseneau J, Canellos G, Banks P, Berard C, Gralnick H, DeVita V. American Burkitt's lymphoma: A clinicopathologic study of 30 cases I. Clinical factors relating to prolonged survival. The American Journal Of Medicine 1975, 58: 314-321. PMID: 1115074, DOI: 10.1016/0002-9343(75)90597-5.
- American Burkitt's lymphoma: A clinicopathologic study of 30 cases II. Pathologic correlationsBanks P, Arseneau J, Gralnick H, Canellos G, DeVita V, Berard C. American Burkitt's lymphoma: A clinicopathologic study of 30 cases II. Pathologic correlations. The American Journal Of Medicine 1975, 58: 322-329. PMID: 163581, DOI: 10.1016/0002-9343(75)90598-7.
- Results of combination chemotherapy of non-Hodgkin's lymphoma.Schein P, Chabner B, Canellos G, Young R, Berard C, DeVita V. Results of combination chemotherapy of non-Hodgkin's lymphoma. British Journal Of Cancer. Supplement 1975, 2: 465-73. PMID: 1101932, PMCID: PMC2149606.
- ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA, A POTENTIALLY CURABLE DISEASE RESULTS WITH COMBINATION CHEMOTHERAPYDevita V, Canellos G, Chabner B, Schein P, Hubbard S, Young R. ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA, A POTENTIALLY CURABLE DISEASE RESULTS WITH COMBINATION CHEMOTHERAPY. The Lancet 1975, 305: 248-250. PMID: 46388, DOI: 10.1016/s0140-6736(75)91142-3.
- Dibromomannitol in the treatment of chronic granulocytic leukemia: a prospective randomized comparison with busulfan.Canellos G, Young R, Neiman P, DeVita V. Dibromomannitol in the treatment of chronic granulocytic leukemia: a prospective randomized comparison with busulfan. Blood 1975, 45: 197-203. PMID: 1054609, DOI: 10.1182/blood.v45.2.197.bloodjournal452197.
- Dibromomannitol in the Treatment of Chronic Granulocytic Leukemia: A Prospective Randomized Comparison With BusulfanCanellos G, Young R, Nieman P, DeVita V. Dibromomannitol in the Treatment of Chronic Granulocytic Leukemia: A Prospective Randomized Comparison With Busulfan. Blood 1975, 45: 197-203. DOI: 10.1182/blood.v45.2.197.197.
- Non‐Hodgkin's lymphoma: Patterns of relapse from complete remission after combination chemotherapySchein P, Chabner B, Canellos G, Young R, Devita V. Non‐Hodgkin's lymphoma: Patterns of relapse from complete remission after combination chemotherapy. Cancer 1975, 35: 354-357. PMID: 1089470, DOI: 10.1002/1097-0142(197502)35:2<354::aid-cncr2820350209>3.0.co;2-2.
- Letter: Combination chemotherapy for breast cancer.Canellos G, DeVita V, Gold G, Chabner B, Schein P, Young R. Letter: Combination chemotherapy for breast cancer. The BMJ 1975, 1: 37. PMID: 1120229, PMCID: PMC1671886, DOI: 10.1136/bmj.1.5948.37-c.
- Reversible penile calcifications associated with bleomycin (NSC-125066)-induced pulmonary toxicity.Ihde D, Gormley P, Francis R, DeVita V. Reversible penile calcifications associated with bleomycin (NSC-125066)-induced pulmonary toxicity. Cancer Chemotherapy Reports 1975, 59: 1039-41. PMID: 54214.
- Combination versus single agent chemotherapy: A review of the basis for selection of drug treatment of cancerDevita V, Young R, Canellos G. Combination versus single agent chemotherapy: A review of the basis for selection of drug treatment of cancer. Cancer 1975, 35: 98-110. PMID: 162854, DOI: 10.1002/1097-0142(197501)35:1<98::aid-cncr2820350115>3.0.co;2-b.
- The design of clinical trials in the therapy of ovarian carcinomaYoung R, DeVita V. The design of clinical trials in the therapy of ovarian carcinoma. American Journal Of Obstetrics And Gynecology 1974, 120: 1012-1024. PMID: 4432892, DOI: 10.1016/0002-9378(74)90143-4.
- Chemotherapy of advanced ovarian carcinoma: A prospective randomized comparison of phenylalanine mustard and high dose cyclophosphamideYoung R, Canellos G, Chabner B, Schein P, Hubbard S, DeVita V. Chemotherapy of advanced ovarian carcinoma: A prospective randomized comparison of phenylalanine mustard and high dose cyclophosphamide. Gynecologic Oncology 1974, 2: 489-497. PMID: 4376998, DOI: 10.1016/0090-8258(74)90059-6.
- Thrombocytosis in Chronic Granulocytic Leukemia: Incidence and Clinical SignificanceMason J, DeVita V, Canellos G. Thrombocytosis in Chronic Granulocytic Leukemia: Incidence and Clinical Significance. Blood 1974, 44: 483-487. PMID: 4528824, DOI: 10.1182/blood.v44.4.483.483.
- Clinical antitumor activity and toxicity of streptozotocin (NSC‐85998)Schein P, O'Connell M, Blom J, Hubbard S, Magrath I, Bergevin P, Wiernik P, Ziegler J, Devita V. Clinical antitumor activity and toxicity of streptozotocin (NSC‐85998). Cancer 1974, 34: 993-1000. PMID: 4371075, DOI: 10.1002/1097-0142(197410)34:4<993::aid-cncr2820340404>3.0.co;2-t.
- Indomethacin-Responsive Hypercalcemia in a Patient with Renal-Cell AdenocarcinomaBrereton H, Halushka P, Alexander R, Mason D, Keiser H, DeVita V. Indomethacin-Responsive Hypercalcemia in a Patient with Renal-Cell Adenocarcinoma. New England Journal Of Medicine 1974, 291: 83-85. PMID: 4835887, DOI: 10.1056/nejm197407112910207.
- Treatment of malignant melanoma with methyl CCNUYoung R, Canellos G, Chabner B, Schein P, Brereton H, DeVita V. Treatment of malignant melanoma with methyl CCNU. Clinical Pharmacology & Therapeutics 1974, 15: 617-622. PMID: 4601745, DOI: 10.1002/cpt1974156617.
- The chemotherapy of ovarian carcinomaYoung R, Hubbard S, DeVita V. The chemotherapy of ovarian carcinoma. Cancer Treatment Reviews 1974, 1: 99-110. DOI: 10.1016/s0305-7372(74)80013-7.
- HL-A Antigens in Hodgkin's Disease: Histopathologic and Clinical CorrelationsGraff K, Simon R, Yankee R, DeVita V, Rogentine G. HL-A Antigens in Hodgkin's Disease: Histopathologic and Clinical Correlations. Journal Of The National Cancer Institute 1974, 52: 1087-1090. PMID: 4826579, DOI: 10.1093/jnci/52.4.1087.
- BCG Vaccine Treatment of Hodgkin DiseaseDeVita V. BCG Vaccine Treatment of Hodgkin Disease. JAMA 1974, 228: 28-28. PMID: 4406143, DOI: 10.1001/jama.1974.03230260022015.
- RECENTLY RECOGNIZED COMPLICATIONS OF CANCER CHEMOTHERAPYArseneau J, Canellos G, DeVita V, Sherins R. RECENTLY RECOGNIZED COMPLICATIONS OF CANCER CHEMOTHERAPY. Annals Of The New York Academy Of Sciences 1974, 230: 481-488. PMID: 4595953, DOI: 10.1111/j.1749-6632.1974.tb14482.x.
- Radiotherapeutic implications of prospective staging in non-Hodgkin's lymphoma.Johnson R, Chretien P, O'Conor G, DeVita V, Thomas L. Radiotherapeutic implications of prospective staging in non-Hodgkin's lymphoma. Radiology 1974, 110: 655-7. PMID: 4811687, DOI: 10.1148/110.3.655.
- Cyclical Combination Chemotherapy for Advanced Breast CarcinomaCanellos G, Devita V, Gold G, Chabner B, Schein P, Young R. Cyclical Combination Chemotherapy for Advanced Breast Carcinoma. The BMJ 1974, 1: 218. PMID: 4818162, PMCID: PMC1633086, DOI: 10.1136/bmj.1.5901.218.
- Potential for Prolonged Disease-free Survival Following Combination Chemotherapy of Non-Hodgkin’s LymphomaSchein P, Chabner B, Canellos G, Young R, Berard C, DeVita V. Potential for Prolonged Disease-free Survival Following Combination Chemotherapy of Non-Hodgkin’s Lymphoma. Blood 1974, 43: 181-189. PMID: 4589318, DOI: 10.1182/blood.v43.2.181.181.
- Lymphocyte Reactivity in Hodgkin's Disease: A Lymphocyte Civil WarDeVita V. Lymphocyte Reactivity in Hodgkin's Disease: A Lymphocyte Civil War. New England Journal Of Medicine 1973, 289: 801-802. PMID: 4542305, DOI: 10.1056/nejm197310112891510.
- Streptozotocin for malignant insulinomas and carcinoid tumor. Report of eight cases and review of the literature.Schein P, Kahn R, Gorden P, Wells S, Devita V. Streptozotocin for malignant insulinomas and carcinoid tumor. Report of eight cases and review of the literature. JAMA Internal Medicine 1973, 132: 555-61. PMID: 4355081, DOI: 10.1001/archinte.132.4.555.
- Editorial: Infection and cancer: old friends.DeVita V, Young C. Editorial: Infection and cancer: old friends. Annals Of Internal Medicine 1973, 79: 597-9. PMID: 4748278, DOI: 10.7326/0003-4819-79-4-597.
- Streptozotocin for Malignant Insulinomas and Carcinoid Tumor: Report of Eight Cases and Review of the LiteratureSchein P, Kahn R, Gorden P, Wells S, DeVita V. Streptozotocin for Malignant Insulinomas and Carcinoid Tumor: Report of Eight Cases and Review of the Literature. JAMA Internal Medicine 1973, 132: 555-561. DOI: 10.1001/archinte.1973.03650100069013.
- Effect of drug treatment for lymphoma on male reproductive capacity. Studies of men in remission after therapy.Sherins R, DeVita V. Effect of drug treatment for lymphoma on male reproductive capacity. Studies of men in remission after therapy. Annals Of Internal Medicine 1973, 79: 216-20. PMID: 4580112, DOI: 10.7326/0003-4819-79-2-216.
- Hodgkin's Disease in ChildhoodYoung R, DeVita V, Johnson R. Hodgkin's Disease in Childhood. Blood 1973, 42: 163-174. PMID: 4793108, DOI: 10.1182/blood.v42.2.163.163.
- MAINTENANCE CHEMOTHERAPY FOR ADVANCED HODGKIN'S DISEASE IN REMISSIONYoung R, Chabner B, Canellos G, Schein P, Devita V. MAINTENANCE CHEMOTHERAPY FOR ADVANCED HODGKIN'S DISEASE IN REMISSION. The Lancet 1973, 301: 1339-1343. PMID: 4122739, DOI: 10.1016/s0140-6736(73)91672-3.
- The Use of Drugs in Combination for the Treatment of Cancer — Rationale and ResultsDeVita V, Schein P. The Use of Drugs in Combination for the Treatment of Cancer — Rationale and Results. New England Journal Of Medicine 1973, 288: 998-1006. PMID: 4348752, DOI: 10.1056/nejm197305102881905.
- Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal.DeVita V. Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal. National Cancer Institute Monograph 1973, 36: 373-9. PMID: 4744596.
- Physiologic disposition of 1‐(2‐chloroethyl)‐3‐cyclohexyl‐1‐nitrosourea (CCNU) and 1‐(2‐chloroethyl)‐3‐(4‐methyl cyclohexyl)‐1‐nitrosourea (MeCCNU) in manSponzo R, Devita V, Oliverio V. Physiologic disposition of 1‐(2‐chloroethyl)‐3‐cyclohexyl‐1‐nitrosourea (CCNU) and 1‐(2‐chloroethyl)‐3‐(4‐methyl cyclohexyl)‐1‐nitrosourea (MeCCNU) in man. Cancer 1973, 31: 1154-1159. PMID: 4705152, DOI: 10.1002/1097-0142(197305)31:5<1154::aid-cncr2820310517>3.0.co;2-b.
- Initial clinical trials with methyl‐ccnu 1‐(2‐chloroethyl)‐3‐(4‐methyl cyclohexyl)‐1‐nitrosourea (meccnu)Young R, Walker M, Canellos G, Schein P, Chabner B, Devita V. Initial clinical trials with methyl‐ccnu 1‐(2‐chloroethyl)‐3‐(4‐methyl cyclohexyl)‐1‐nitrosourea (meccnu). Cancer 1973, 31: 1164-1169. PMID: 4705154, DOI: 10.1002/1097-0142(197305)31:5<1164::aid-cncr2820310519>3.0.co;2-4.
- Intensive chemotherapy for Hodgkin's disease: long-term complications.DeVita V, Arseneau J, Sherins R, Canellos G, Young R. Intensive chemotherapy for Hodgkin's disease: long-term complications. National Cancer Institute Monograph 1973, 36: 447-54. PMID: 4744600.
- Diagnosis of liver involvement by lymphoma: Results in 96 consecutive peritoneoscopiesBagley C, Thomas L, Johnson R, Chretien P, Devita V. Diagnosis of liver involvement by lymphoma: Results in 96 consecutive peritoneoscopies. Cancer 1973, 31: 840-847. PMID: 4267529, DOI: 10.1002/1097-0142(197304)31:4<840::aid-cncr2820310412>3.0.co;2-w.
- Liver‐spleen scan in hodgkin's diseaseMilder M, Larson S, Bagley C, Devita V, Johnson R, Johnston G. Liver‐spleen scan in hodgkin's disease. Cancer 1973, 31: 826-834. PMID: 4706049, DOI: 10.1002/1097-0142(197304)31:4<826::aid-cncr2820310410>3.0.co;2-m.
- Combination Chemotherapy and Survival in Advanced Hodgkin's DiseaseCanellos G, Young R, Berard C, DeVita V. Combination Chemotherapy and Survival in Advanced Hodgkin's Disease. JAMA Internal Medicine 1973, 131: 388-390. PMID: 4569375, DOI: 10.1001/archinte.1973.00320090078008.
- Immune Alterations in Hodgkin's Disease: Effect of Delayed Hypersensitivity and Lymphocyte Transformation on Course and SurvivalYoung R, Corder M, Berard C, DeVita V. Immune Alterations in Hodgkin's Disease: Effect of Delayed Hypersensitivity and Lymphocyte Transformation on Course and Survival. JAMA Internal Medicine 1973, 131: 446-454. DOI: 10.1001/archinte.1973.00320090136016.
- Immune alterations in Hodgkin's disease. Effect of delayed hypersensitivity and lymphocyte transformation on course and survival.Young R, Corder M, Berard C, DeVita V. Immune alterations in Hodgkin's disease. Effect of delayed hypersensitivity and lymphocyte transformation on course and survival. JAMA Internal Medicine 1973, 131: 446-54. PMID: 4574227, DOI: 10.1001/archinte.131.3.446.
- Clinical pharmacology of cyclophosphamide.Bagley C, Bostick F, DeVita V. Clinical pharmacology of cyclophosphamide. Cancer Research 1973, 33: 226-33. PMID: 4688880.
- Current chemotherapeutic combinations.DeVita V, Carbone P. Current chemotherapeutic combinations. Series Haematologica (1968) 1973, 6: 182-95. PMID: 4593779.
- High-dose intermittent intravenous infusion of procarbazine (NSC-77213).Chabner B, Sponzo R, Hubbard S, Canellos G, Young R, Schein P, Devita V. High-dose intermittent intravenous infusion of procarbazine (NSC-77213). Cancer Chemotherapy Reports 1973, 57: 361-3. PMID: 4584487.
- Ovarian carcinoma metastatic to the diaphragm—frequently undiagnosed at laparotomy A preliminary reportBagley C, Young R, Schein P, Chabner B, Devita V. Ovarian carcinoma metastatic to the diaphragm—frequently undiagnosed at laparotomy A preliminary report. American Journal Of Obstetrics And Gynecology 1973, 116: 397-400. PMID: 4267636, DOI: 10.1016/s0002-9378(15)31299-0.
- A decade of combination chemotherapy of advanced Hodgkin's diseaseDevita V, Canellos G, Moxley J. A decade of combination chemotherapy of advanced Hodgkin's disease. Cancer 1972, 30: 1495-1504. PMID: 4565815, DOI: 10.1002/1097-0142(197212)30:6<1495::aid-cncr2820300613>3.0.co;2-i.
- Nonlymphomatous Malignant Tumors Complicating Hodgkin's Disease — Possible Association with Intensive TherapyArseneau J, Sponzo R, Levin D, Schnipper L, Bonner H, Young R, Canellos G, Johnson R, DeVita V. Nonlymphomatous Malignant Tumors Complicating Hodgkin's Disease — Possible Association with Intensive Therapy. New England Journal Of Medicine 1972, 287: 1119-1122. PMID: 5082192, DOI: 10.1056/nejm197211302872204.
- Hodgkin's Disease Therapeutic ProgramDeVita V. Hodgkin's Disease Therapeutic Program. JAMA 1972, 222: 1171-1171. PMID: 4678060, DOI: 10.1001/jama.1972.03210090051025.
- THE EFFECT OF CHEMOTHERAPY ON THE GROWTH OF LEUKEMIA L1210 II. PERSISTENCE OF A NITROSOUREA‐INDUCED CHANGE IN THE GROWTH CHARACTERISTICS OF TRANSPLANT GENERATIONSDeVita V, Bray D, Bostick F, Bagley C. THE EFFECT OF CHEMOTHERAPY ON THE GROWTH OF LEUKEMIA L1210 II. PERSISTENCE OF A NITROSOUREA‐INDUCED CHANGE IN THE GROWTH CHARACTERISTICS OF TRANSPLANT GENERATIONS. Cell Proliferation 1972, 5: 459-466. PMID: 4654583, DOI: 10.1111/j.1365-2184.1972.tb00384.x.
- Treatment of Ovarian Carcinoma: Possibilities for ProgressBagley C, Young R, Canellos G, DeVita V. Treatment of Ovarian Carcinoma: Possibilities for Progress. New England Journal Of Medicine 1972, 287: 856-862. PMID: 4561148, DOI: 10.1056/nejm197210262871705.
- Clinical study with bleomycin: Tolerance to twice weekly dosageOhnuma T, Selawry O, Holland J, DeVita V, Shedd D, Hansen H, Muggia F. Clinical study with bleomycin: Tolerance to twice weekly dosage. Cancer 1972, 30: 914-922. PMID: 4116909, DOI: 10.1002/1097-0142(197210)30:4<914::aid-cncr2820300409>3.0.co;2-8.
- An Increasing Awareness of Pneumocystis carinii PneumonitisRobbins J, DeVita V. An Increasing Awareness of Pneumocystis carinii Pneumonitis. The Annals Of Thoracic Surgery 1972, 14: 445-447. PMID: 4538515, DOI: 10.1016/s0003-4975(10)65252-6.
- Combination chemotherapy for advanced Hodgkin's disease in relapse following extensive radiotherapyCanellos G, Young R, DeVita V. Combination chemotherapy for advanced Hodgkin's disease in relapse following extensive radiotherapy. Clinical Pharmacology & Therapeutics 1972, 13: 750-754. PMID: 5053816, DOI: 10.1002/cpt1972135part1750.
- Late Recurrence of Testicular TumorChabner B, Canellos G, Olweny C, DeVita V. Late Recurrence of Testicular Tumor. New England Journal Of Medicine 1972, 287: 413. PMID: 5065110, DOI: 10.1056/nejm197208242870817.
- In vivo tumor cell kinetic studies: use of local thymidine injection followed by fine-needle aspiration.Muggia F, DeVita V. In vivo tumor cell kinetic studies: use of local thymidine injection followed by fine-needle aspiration. Translational Research 1972, 80: 297-301. PMID: 5044784.
- Treatment of Hodgkin's disease in private practiceDeVita V. Treatment of Hodgkin's disease in private practice. JAMA 1972, 221: 298-299. DOI: 10.1001/jama.221.3.298.
- Treatment of Hodgkin's Disease in Private PracticeDeVita V. Treatment of Hodgkin's Disease in Private Practice. JAMA 1972, 221: 298-299. PMID: 5067795, DOI: 10.1001/jama.1972.03200160048014.
- Clinical trials with 5-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196) given intravenously.Bagley C, Canellos G, Young R, Gallelli J, Devita V. Clinical trials with 5-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196) given intravenously. Cancer Chemotherapy Reports 1972, 56: 387-91. PMID: 19051499.
- Phytohemagglutinin-induced Lymphocyte Transformation: The Relationship to Prognosis of Hodgkin's DiseaseCorder M, Young R, Brown R, DeVita V. Phytohemagglutinin-induced Lymphocyte Transformation: The Relationship to Prognosis of Hodgkin's Disease. Blood 1972, 39: 595-601. PMID: 5022714, DOI: 10.1182/blood.v39.5.595.595.
- Treatment of the lymphomas.DeVita V, Canellos G. Treatment of the lymphomas. Seminars In Hematology 1972, 9: 193-209. PMID: 4111886.
- Preliminary clinical trials of dichloromethotrexate (NSC-29630) in hepatocellular carcinoma.Vogel C, Adamson R, DeVita V, Johns D, Kyalwazi S. Preliminary clinical trials of dichloromethotrexate (NSC-29630) in hepatocellular carcinoma. Cancer Chemotherapy Reports 1972, 56: 249-58. PMID: 4339634.
- Advanced lymphosarcoma: intensive cyclical combination chemotherapy with cyclophosphamide, vincristine, and prednisone.Bagley C, Devita V, Berard C, Canellos G. Advanced lymphosarcoma: intensive cyclical combination chemotherapy with cyclophosphamide, vincristine, and prednisone. Annals Of Internal Medicine 1972, 76: 227-34. PMID: 5066691, DOI: 10.7326/0003-4819-76-2-227.
- Liver biopsy in Hodgkin's disease. Clinicopathologic correlations in 127 patients.Bagley C, Roth J, Thomas L, Devita V. Liver biopsy in Hodgkin's disease. Clinicopathologic correlations in 127 patients. Annals Of Internal Medicine 1972, 76: 219-25. PMID: 4257911, DOI: 10.7326/0003-4819-76-2-219.
- Delayed hypersensitivity in Hodgkin's disease A study of 103 untreated patientsYoung R, Corder M, Haynes H, DeVita V. Delayed hypersensitivity in Hodgkin's disease A study of 103 untreated patients. The American Journal Of Medicine 1972, 52: 63-72. PMID: 5058359, DOI: 10.1016/0002-9343(72)90008-3.
- Arteriography of an ileal carcinoid tumor.Shimkin P, DeVita V, Doppman J. Arteriography of an ileal carcinoid tumor. Canadian Association Of Radiologists Journal 1971, 22: 259-60. PMID: 5136948.
- Hematologic and Cytogenetic Remission of Blastic Transformation in Chronic Granulocytic LeukemiaCanellos G, DeVita V, Whang-Peng J, Carbone P. Hematologic and Cytogenetic Remission of Blastic Transformation in Chronic Granulocytic Leukemia. Blood 1971, 38: 671-679. PMID: 5288508, DOI: 10.1182/blood.v38.6.671.671.
- Peritoneoscopy in the staging of Hodgkin's disease.DeVita V, Bagley C, Goodell B, O'Kieffe D, Trujillo N. Peritoneoscopy in the staging of Hodgkin's disease. Cancer Research 1971, 31: 1746-50. PMID: 4256359.
- Chemotherapeutic implications of staging in Hodgkin's disease.DeVita V, Carbone P. Chemotherapeutic implications of staging in Hodgkin's disease. Cancer Research 1971, 31: 1838-44. PMID: 4941352.
- Report of the Committee on Hodgkin's Disease Staging Procedures.Rosenberg S, Boiron M, DeVita V, Johnson R, Lee B, Ultmann J, Viamonte M. Report of the Committee on Hodgkin's Disease Staging Procedures. Cancer Research 1971, 31: 1862-3. PMID: 5121695.
- Treatment of Advanced Hodgkin's Disease with [1,3 Bis (2-Chloroethyl)-L-Nitrosourea] BCNUYoung R, DeVita V, Serpick A, Canellos G. Treatment of Advanced Hodgkin's Disease with [1,3 Bis (2-Chloroethyl)-L-Nitrosourea] BCNU. New England Journal Of Medicine 1971, 285: 475-479. PMID: 5558887, DOI: 10.1056/nejm197108262850902.
- Delayed Hypersensitivity in Patients with CancerCorder M, Young R, DeVita V. Delayed Hypersensitivity in Patients with Cancer. New England Journal Of Medicine 1971, 285: 522-524. PMID: 5558895, DOI: 10.1056/nejm197108262850917.
- HODGKIN'S DISEASEDevita V. HODGKIN'S DISEASE. The Lancet 1971, 298: 46-47. PMID: 4103688, DOI: 10.1016/s0140-6736(71)90032-8.
- Anergy and tryptophan metabolism in Hodgkin’s diseaseDeVita V, Chabner B, Livingston D, Oliverio V. Anergy and tryptophan metabolism in Hodgkin’s disease. American Journal Of Clinical Nutrition 1971, 24: 835-840. PMID: 5091524, DOI: 10.1093/ajcn/24.7.835.
- Effects of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) and its degradation products on progression of L1210 cells through the cell cycle.Bray D, DeVita V, Adamson R, Oliverio V. Effects of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) and its degradation products on progression of L1210 cells through the cell cycle. Cancer Chemotherapy Reports 1971, 55: 215-20. PMID: 5115843.
- Preliminary clinical trials and clinical pharmacologic studies with 5-(3,3-bis(2-chloroethyl)-1-triazeno)-imidazole-4-carboxamide (NSC-82196) given orally.Vogel C, DeVita V, Denham C, Foley H, Field R, Carbone P. Preliminary clinical trials and clinical pharmacologic studies with 5-(3,3-bis(2-chloroethyl)-1-triazeno)-imidazole-4-carboxamide (NSC-82196) given orally. Cancer Chemotherapy Reports 1971, 55: 159-65. PMID: 5118685.
- Hypercalcemia in chronic granulocytic leukemiaHaskell C, Devita V, Canellos G. Hypercalcemia in chronic granulocytic leukemia. Cancer 1971, 27: 872-880. PMID: 5280374, DOI: 10.1002/1097-0142(197104)27:4<872::aid-cncr2820270417>3.0.co;2-d.
- Studies on the Anti-Tumor Action of Poly I: Poly CLevy H, Adamson R, Carbone P, DeVita V, Gazdar A, Rhim J, Weinstein A, Riley F. Studies on the Anti-Tumor Action of Poly I: Poly C. 1971, 55-65. DOI: 10.1007/978-3-642-85772-0_5.
- Combination Chemotherapy With Nitrogen Mustard, Vincristine, Procarbazine and Prednisone in Previously Treated Patients With Hodgkin's DiseaseLOWENBRAUN S, DEVITA V, SERPICK A. Combination Chemotherapy With Nitrogen Mustard, Vincristine, Procarbazine and Prednisone in Previously Treated Patients With Hodgkin's Disease. Blood 1970, 36: 704-717. PMID: 5488687, DOI: 10.1182/blood.v36.6.704.704.
- Combination chemotherapy in the treatment of advanced Hodgkin's disease.Devita V, Serpick A, Carbone P. Combination chemotherapy in the treatment of advanced Hodgkin's disease. Annals Of Internal Medicine 1970, 73: 881-95. PMID: 5525541, DOI: 10.7326/0003-4819-73-6-881.
- Löffler's Syndrome as a Complication of Bipedal LymphangiographyBray D, Brown C, Herdt J, DeVita V. Löffler's Syndrome as a Complication of Bipedal Lymphangiography. JAMA 1970, 214: 369-371. PMID: 5469078, DOI: 10.1001/jama.1970.03180020087020.
- Pneumocystis carinii Pneumonia.Mansour N, DeVita V, Goodell B. Pneumocystis carinii Pneumonia. Annals Of Internal Medicine 1970, 73: 342-3. PMID: 5311515, DOI: 10.7326/0003-4819-73-2-342.
- Pentamidine: Clinical pharmacologic correlations in man and miceWaalkes T, Denham C, DeVita V. Pentamidine: Clinical pharmacologic correlations in man and mice. Clinical Pharmacology & Therapeutics 1970, 11: 505-512. PMID: 5310706, DOI: 10.1002/cpt1970114505.
- CELL CYCLE CHARACTERISTICS OF HUMAN SOLID TUMORS IN VIVOYoung R, DeVita V. CELL CYCLE CHARACTERISTICS OF HUMAN SOLID TUMORS IN VIVO. Cell Proliferation 1970, 3: 285-290. PMID: 5523056, DOI: 10.1111/j.1365-2184.1970.tb00273.x.
- Pyridoxine and Anergy in Hodgkin's DiseaseChabner P, DeVita V, Livingston D, Oliverio V. Pyridoxine and Anergy in Hodgkin's Disease. New England Journal Of Medicine 1970, 282: 1326. PMID: 5442374, DOI: 10.1056/nejm197006042822322.
- The effect of chemotherapy on the growth characteristics and cellular kinetics of leukemia L1210.Young R, DeVita V. The effect of chemotherapy on the growth characteristics and cellular kinetics of leukemia L1210. Cancer Research 1970, 30: 1789-94. PMID: 5457940.
- The physiological disposition of the carcinostatic imidazole-4 (or 5)-carboxamide, 5(or 4)-[3,3-bis(2-chloroethyl)-1-triazeno] (NSC 82196) (imidazole mustard) in mice and dogs.Vogel C, Denham C, Waalkes T, DeVita V. The physiological disposition of the carcinostatic imidazole-4 (or 5)-carboxamide, 5(or 4)-[3,3-bis(2-chloroethyl)-1-triazeno] (NSC 82196) (imidazole mustard) in mice and dogs. Cancer Research 1970, 30: 1651-7. PMID: 5457935.
- he determination of pentamidine (4,4'-diamidinophenoxypentane) in plasma, urine, and tissues.Waalkes T, DeVita V. he determination of pentamidine (4,4'-diamidinophenoxypentane) in plasma, urine, and tissues. Translational Research 1970, 75: 871-8. PMID: 5442852.
- Combination chemotherapy with nitrogen mustard, vincristine, procarbazine, and prednisone in lymphosarcoma and reticulum cell sarcomaLowenbraun S, DeVita V, Serpick A. Combination chemotherapy with nitrogen mustard, vincristine, procarbazine, and prednisone in lymphosarcoma and reticulum cell sarcoma. Cancer 1970, 25: 1018-1025. PMID: 4910254, DOI: 10.1002/1097-0142(197005)25:5<1018::aid-cncr2820250505>3.0.co;2-a.
- Abnormalities of Tryptophan Metabolism and Plasma Pyridoxal Phosphate in Hodgkin's DiseaseChabner B, DeVita V, Livingston D, Oliverio V. Abnormalities of Tryptophan Metabolism and Plasma Pyridoxal Phosphate in Hodgkin's Disease. New England Journal Of Medicine 1970, 282: 838-843. PMID: 5418547, DOI: 10.1056/nejm197004092821504.
- THE SPECTRUM OF THE DISEASE IN 98 PATIENTSYOUNG R, BENNETT J, VOGEL C, CARBONE P, DEVITA V. THE SPECTRUM OF THE DISEASE IN 98 PATIENTS. Medicine 1970, 49: 147-173. PMID: 4913991, DOI: 10.1097/00005792-197003000-00002.
- Pneumocystis carinii: the spectrum of diffuse interstitial pneumonia in patients with neoplastic diseases.Goodell B, Jacobs J, Powell R, DeVita V. Pneumocystis carinii: the spectrum of diffuse interstitial pneumonia in patients with neoplastic diseases. Annals Of Internal Medicine 1970, 72: 337-40. PMID: 5308994, DOI: 10.7326/0003-4819-72-3-337.
- Plasma Pyridoxal Phosphate Depletion by the Carcinostatic ProcarbazineChabner B, DeVita V, Considine N, Oliverio V. Plasma Pyridoxal Phosphate Depletion by the Carcinostatic Procarbazine. Experimental Biology And Medicine 1969, 132: 1119-1122. PMID: 5360989, DOI: 10.3181/00379727-132-34378.
- Needle biopsy in pseudocystis carinii pneumonia.Jacobs J, Vogel C, Powell R, DeVita V. Needle biopsy in pseudocystis carinii pneumonia. Radiology 1969, 93: 525-30. PMID: 5307241, DOI: 10.1148/93.3.525.
- Familial chronic lymphocytic leukemia.Fraumeni J, Vogel C, DeVita V. Familial chronic lymphocytic leukemia. Annals Of Internal Medicine 1969, 71: 279-84. PMID: 4184386, DOI: 10.7326/0003-4819-71-2-279.
- The thymidine-14C and -3H double-labeling technic in the study of the cell cycle of L1210 leukemia ascites tumor in vivo.Young R, DeVita V, Perry S. The thymidine-14C and -3H double-labeling technic in the study of the cell cycle of L1210 leukemia ascites tumor in vivo. Cancer Research 1969, 29: 1581-4. PMID: 5807231.
- Aspergillus Lobar PneumoniaYoung R, Vogel C, DeVita V. Aspergillus Lobar Pneumonia. JAMA 1969, 208: 1156-1162. PMID: 5818713, DOI: 10.1001/jama.1969.03160070034008.
- Relationship of normal CDF1 mouse leukocyte kinetics to growth characteristics of leukemia L1210.DeVita V, Denham C, Perry S. Relationship of normal CDF1 mouse leukocyte kinetics to growth characteristics of leukemia L1210. Cancer Research 1969, 29: 1067-71. PMID: 5781099.
- Pneumocystis carinii Pneumonia — Successful Diagnosis and Treatment of Two Patients with Associated Malignant ProcessesDeVita V, Emmer M, Levine A, Jacobs B, Berard C. Pneumocystis carinii Pneumonia — Successful Diagnosis and Treatment of Two Patients with Associated Malignant Processes. New England Journal Of Medicine 1969, 280: 287-291. PMID: 5303991, DOI: 10.1056/nejm196902062800602.
- Shaking chills related to occult lymphoma. Report of a case.Chabner B, Easton J, DeVita V. Shaking chills related to occult lymphoma. Report of a case. The Medical Annals Of The District Of Columbia 1969, 38: 27-8. PMID: 5249871.
- Announcement of formation of: The lymphoma task force and pathology reference centerDevita V, Rappaport H, Frei E. Announcement of formation of: The lymphoma task force and pathology reference center. Cancer 1968, 22: 1087-1088. DOI: 10.1002/1097-0142(196811)22:6<1087::aid-cncr2820220602>3.0.co;2-b.
- Pharmacologic aspects of the chemotherapy of solid tumors.DeVita V, Rall D. Pharmacologic aspects of the chemotherapy of solid tumors. Rational Drug Therapy 1968, 2: 1-6. PMID: 5743792.
- Severe vinblastine-induced leukopenia during late pregnancy with delivery of a normal infant.Nordlund J, DeVita V, Cabbone P. Severe vinblastine-induced leukopenia during late pregnancy with delivery of a normal infant. Annals Of Internal Medicine 1968, 69: 581-2. PMID: 5673176, DOI: 10.7326/0003-4819-69-3-581.
- Heart in malignant lymphoma (Hodgkin's disease, lymphosarcoma, reticulum cell sarcoma and mycosis fungoides) A study of 196 autopsy cases∗Roberts W, Glancy D, Devita V. Heart in malignant lymphoma (Hodgkin's disease, lymphosarcoma, reticulum cell sarcoma and mycosis fungoides) A study of 196 autopsy cases∗. The American Journal Of Cardiology 1968, 22: 85-107. PMID: 4873149, DOI: 10.1016/0002-9149(68)90250-6.
- Bone-Marrow Biopsy in Hodgkin's DiseaseBennett J, Gralnick H, Devita V. Bone-Marrow Biopsy in Hodgkin's Disease. New England Journal Of Medicine 1968, 278: 1179. PMID: 5646722, DOI: 10.1056/nejm196805232782120.
- Antitumor activity and some pharmacologic properties of anthramycin methyl ether.Adamson R, Hart L, DeVita V, Oliverio V. Antitumor activity and some pharmacologic properties of anthramycin methyl ether. Cancer Research 1968, 28: 343-7. PMID: 5641523.
- Pneumocystis carinii pneumonia.Vogel C, Cohen M, Powell R, DeVita V. Pneumocystis carinii pneumonia. Annals Of Internal Medicine 1968, 68: 97-108. PMID: 5299825, DOI: 10.7326/0003-4819-68-1-97.
- The physiological disposition of the carcinostatic 1,3‐bis(2‐chloroethyU‐l‐nitrosourea (BCNU) in man and animalsDeVita V, Denham C, Davidson J, Oliverio V. The physiological disposition of the carcinostatic 1,3‐bis(2‐chloroethyU‐l‐nitrosourea (BCNU) in man and animals. Clinical Pharmacology & Therapeutics 1967, 8: 566-577. PMID: 4951973, DOI: 10.1002/cpt196784566.
- Treatment of Hodgkin's disease.DeVita V, Carbone P. Treatment of Hodgkin's disease. The Medical Annals Of The District Of Columbia 1967, 36: 232-4 passim. PMID: 5232852.
- Pigmentation Due to a New Antitumor Agent: Effects of Topical Application of BCNU [1,3-Bis(2-Chloroethyl)-1-Nitrosourea]FROST P, DeVITA V. Pigmentation Due to a New Antitumor Agent: Effects of Topical Application of BCNU [1,3-Bis(2-Chloroethyl)-1-Nitrosourea]. JAMA Dermatology 1966, 94: 265-268. DOI: 10.1001/archderm.1966.01600270015003.
- Pigmentation due to a new antitumor agent. Effects of topical application of BCNU [1,3-bis(2-chloroethyl)-1-nitrosourea].Frost P, DeVita V. Pigmentation due to a new antitumor agent. Effects of topical application of BCNU [1,3-bis(2-chloroethyl)-1-nitrosourea]. JAMA Dermatology 1966, 94: 265-8. PMID: 4951807, DOI: 10.1001/archderm.94.3.265.
- Preliminary clinical studies with ibenzmethyzinDeVita V, Serpick A, Carbone P. Preliminary clinical studies with ibenzmethyzin. Clinical Pharmacology & Therapeutics 1966, 7: 542-546. PMID: 5939977, DOI: 10.1002/cpt196674542.
- Approaches to improving the chemotherapy of Hodgkin's disease.Frei E, DeVita V, Moxley J, Carbone P. Approaches to improving the chemotherapy of Hodgkin's disease. Cancer Research 1966, 26: 1284-9. PMID: 5947352.
- Candida MeningitisDeVITA V, UTZ J, WILLIAMS T, CARBONE P. Candida Meningitis. JAMA Internal Medicine 1966, 117: 527-535. PMID: 5906646, DOI: 10.1001/archinte.1966.03870100055011.
- Candida meningitisDeVita V. Candida meningitis. JAMA Internal Medicine 1966, 117: 527-535. DOI: 10.1001/archinte.117.4.527.
- Pseudohyperkalemia Due to Release of Potassium from White Blood Cells during ClottingBronson W, DeVita V, Carbone P, Cotlove E. Pseudohyperkalemia Due to Release of Potassium from White Blood Cells during Clotting. New England Journal Of Medicine 1966, 274: 369-375. PMID: 5216594, DOI: 10.1056/nejm196602172740702.
- PULMONARY MANIFESTATIONS OF PRIMARY HEPATIC CARCINOMADeVita V, Trujillo N, Blackman A, Ticktin H. PULMONARY MANIFESTATIONS OF PRIMARY HEPATIC CARCINOMA. The American Journal Of The Medical Sciences 1965, 250: 428-436. PMID: 4284660, DOI: 10.1097/00000441-196510000-00009.
- ANTEPARTUM THROMBOPHLEBITIS AND PULMONARY EMBOLIZATION. REPORT OF A CASE AND REVIEW OF THE LITERATURE.DEVITA V, WIENER L, MASSUMI R. ANTEPARTUM THROMBOPHLEBITIS AND PULMONARY EMBOLIZATION. REPORT OF A CASE AND REVIEW OF THE LITERATURE. The Medical Annals Of The District Of Columbia 1965, 34: 177-80. PMID: 14263570.
- SOME PHARMACOLOGIC PROPERTIES OF A NEW ANTITUMOR AGENT, N-ISOPROPYL-ALPHA-(2-METHYLHYDRAZINO)-P-TOLUAMIDE, HYDROCHLORIDE (NSC-77213).OLIVERIO V, DENHAM C, DEVITA V, KELLY M. SOME PHARMACOLOGIC PROPERTIES OF A NEW ANTITUMOR AGENT, N-ISOPROPYL-ALPHA-(2-METHYLHYDRAZINO)-P-TOLUAMIDE, HYDROCHLORIDE (NSC-77213). Cancer Chemotherapy Reports 1964, 42: 1-7. PMID: 14226125.